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ABSTRACT
Sanguinarine is a potential anti-cancer drug belonging to the benzophenanthridine
alkaloids. K562 erythroleukemia cells treated with sanguinarine at ooncentrations of 1.5
l1g/m1 for 2 hours displayed the morphology of apoplosis or programmed cell death
(peO) and at 12.5 Jlglml. displayed the morphology of blister formation or blister cell
death (BCD). This dual modality of cell death processes was coined "bimodal cell death"
(BMeO). The present study is devoted to the cellular and molecular characterization of
bimodal cell death.
Sanguinarine-induced peD in the Bcl-2 (anti·apoptotic) low-expressing K562
erythroleukemia cells was found 10 have increased expression of the pro-apoplotic Bax:
protein as well as caspase-3 activation, whereas BCD was found to have neither. eDNA
expression array analysis of sanguinarine induced PCD in K562 cells failed to reveal the
presence of Bax at the gene transcript level, which suggests the relevance of post-
translational modification of proteins as opposed to its de novo synthesis. On the other
hand, high Bd-2 protein expressing JMI pre.B lymphoblastic cells. when treated with
sanguinarine, failed to undergo the morphology of either PCD or BCD, Western blotting
analysis of JMI cells treated with sanguinarine showed an increase in Bcl-2 protein, over
and above its high endogenous levels while there was no detectable Bax expression or
caspase-3 activation. Bel·2 appeared to have played the role of being anti-PCD as well as
anti-BCD in JM I cells during sanguinarine treatment. The role of several olher members
of the Bcl-2 family: Bad, Bak, Bel-XL, Bel·xs, Hrk, NBK, Bik, Bid as well as the tumour
suppressor protein p53 was found to be negligible.
A comparative analysis of PCD and BCD in K562 and lMl cells treated with
sanguinarine was also done at the cellular level using the following methods: light and
electron microscopy; terminal deoxynucleotidyl transferase (TdT) end labeling; 3lCr
release; trypan blue exclusion; propidium iodide exclusion and annexin-V-binding. These
studies further characterized PCD and BCD at the cellular level in K562 cells, and at the
same time highlighted the anti·PCD and anti-BCD roles played by Bcl-2 in sanguinarine-
resistantlMl cells
Immunofluorescence·flow cytometry studies of protein expression in K562 cells
treated with sanguinarine showed a high percentage ofBax positive cells with low levels
of the nuclear transcription factor NF-KB in PCD, and a high percentage of Bax negative
cells with high levels ofI\'f-KB in BCD. lMl cells showed elevated levels of Bcl-Z in
response to sanguinarine treatment. This flow cytometry study also helped confirm the
findings of Western blot analysis. Thus, the interaction between Bcl·2, Bax and NF-KB
might be crucial to understand sanguinarine·induced PCD and BCD
Sanguinarine was also found to overcome the P-glycoprotein-mediated drug
effiux pump, widely believed to be associated with the classical multidrug resistant
(MDR) phenomenon, in the vinblastin resistant CEM-VLB leukemia cells. Studies
pertaining to the cellular and molecular parameters of sanguinarine induced PCD and
BCD in the MDR CEM-VLB cells and in their wild type counterparts CEM·T4 (p.gp
negative), showed that the bimodal cell death pattern in both cell lines was qualitatively
similar. Moreover, flowcytometric studies in these cells showed an increased presence of
sanguinarine in cells during BCD but not PCD Thus, the phenomenon of BCD,
iii
associated with elevated intracellular levels of sanguinarine, may have had a role to play
in overcoming the P-gp mediated multidrug resistance.
Understanding different cell death mechanisms of individual anti-cancer agents
may lead to their effective administration, alone or in combination with other established
therapies. Accordingly, we have attempted to characterize the novel form of cell death-
BCD, described in literature as the "blebbing phenomenon", and propose it as a fonn of
cell death, distinct from apoptosis
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Background
1.1. Incidence of Cancer
In normal cell growth there exists a finely controlled balance between growth.
promoting and growth-restraining signals such that proliferation occurs only when
required. This process is disrupted in tumour cells with continued cell proliferation and
loss of differentiation. In addition, the normal process of programmed cell death may no
longer operate (Macdonald and Ford, 1997). Thus, in its simplest terms cancer represents
an accelerating process of inappropriate, uncontrolled cell growth - a chaotic process
within the order of biology. The number of cancer cases continues to rise. panicularly
among the elderly. This association is attributed 10 factors such as. duration of
carcinogenesis, increased SU5CCptibilily of older tisuue 10 carcinogens and general
systemic effects of aging of me body, for example, aging of the immune system
(Balducci and Beghe, 2001). This rise in the incidence of cancer is accompanied by a
corresponding increase in the interest in complementary therapies including the need for
innovative anticancer substances (Morris el at., 2000). It is our belief that a bener
understanding of the mechanisms of tumour cell killing by potential anti-cancer agents
might contribute towards Ihe discovery of novel therapies.
1.2. Overview of Cell Death: Apoptosis, Accidental Cell Death, The
"Blebbing" Phenomenon and Necrosis
Increasing attention is now devoted to elucidating differences in cell death under
pathological and physiological conditions. In fact, an ad hoc committee of the society of
toxicologic pathologists are, at present, in the process of forging a consensus on the
nomenclature of the various fonns of cell death (Levin et aI., 1999). The pathways and
identification of cell death is of key importance to the practice of diagnostic and research
in toxicologic pathology (Trump et aI., 1997)
Studies of dying cells have showed that there are two major mechanisms involved
in cell death, namely apoptosis (programmed cell death) and accidental cell death (Majno
and loris, 1995). Majno and loris (1995) suggest that the most satisfactory term for cell
death not by apoptosis is accidental cell death. According to these authors the tenn
necrosis is inappropriate as it does not indicate a form of cell death, but merely refers to
changes that take place after cells die. One well-known fonn of accidental cell death is
ischemic cell death. The tenn "oncosis" has been proposed for ischemic cell death, as it is
accompanied by swelling (Majno and loris, 1995; Darzynkiewicz et aI., 1997)
Apoptosis is a process of programmed cell death in which a cell activates an
intrinsic suicide mechanism that ultimately destroys the cell (Leach, 1998). This cell
death process is necessary for development and homeostasis, for defence, and for
removal of aging cells (Vaux and Strasser, 1996). The term apoptosis is a word derived
from the Greek language: apo. for "apan" and ptosis, for ''fallen'' to describe the
dropping off or falling off of petals from flowers or shedding of leaves from trees (Kerr et
al., 1972; Cohen, 1993; Veda and Shah, 1994).
Apoptosis is also an active process, which requires energy in the form of ATP to
maintain cellular integrity (Fesus et ai., 1991; Eastman, 1993), This energy is necessary
along with RNA and protein synthesis to fabricate the molecules needed for the
successful completion ofapoptosis (Eastman, 1993). However, not all apoptotic cells are
involved in de 1I0VO protein synthesis; it is well known that post translational
modification (conformational changes) of already synthesized proteins can also lead to
cell death by apoptosis (Reed, 2000; Liu et aI., 1994). In addition, this cell death process
requires only single scattered cells (Veda and Shah, 1994; Kerr et al., 1994). The cell
committed to undergo apoptosis first loses contact with its neighbours by receiving
extracellular signals in the form of increased Ca++ (Fesus et al., 1991; Ameisen, 1996)
This causes rapid loss of water and ions resulting in condensation of cytoplasm and
nuclear constituents (Ameisen, 1996). As the nucleus begins to condense it forms
peripheral chromatin caps that line the nuclear membrane (Fesus et aI., 1991; Veda and
Shah, 1994). The nucleus continues to condense until it becomes dark and pyknotic, a
characteristic that is a hallmark of an apoptotic nucleus (Cohen, 1993). Later, complex
invaginations develop in the nuclear membrane resulting in multiple segmented nuclei
(Veda and Shah, 1994). As the cell loses cytoplasmic volume, the plasma membrane
becomes ruffled and blebbed (Cohen, 1993). This wrinkling zeiotic plasma membrane
leads to cellular fragmentation (Cohen, 1993). The fragments that are formed are called
apoptotic bodies. These bodies contain the condensed cytoplasmic proteins and intact
organelles along with nuclear fragments (Cohen, 1993). This process occurs very quickly
within a time frame of about four hours without causing damage to surrounding cells or
tissues (Cohen, 1993). This rapid phagocytosis is critical in maintaining physiologic
balance, thus avoiding an inflammatory response (Kerr et al., 1994)
When the DNA of these apoptotic bodies is analyzed by gel electrophoresis, the
pattern observed is one of distinct bands thai give a "ladder" appearance. Each cleavage
is at an interval of about 200 base pairs between the nucleosome linker regions (Cohen,
1993). These so called "ladder structures" of apoptotic nucleosomal DNA are widely
used as biochemical markers of apoptosis (Zhitovsky et aI., 1994). It has been proposed
that this event happens early in the process to serve as a protective measure to the nearby
phagocytic cells by destroying the unwanted potentially damaged genetic information
(Kerr et a/., 1994). However, some repons in the literature suggests that intemucleosomal
DNA fragmentation may not occur in some experimental systems (Liepins and
Bustamante, 1994; Stewan, 1994), although considered to be a hallmark of apoptosis
(Arends et al., 1990; Compton, 1992).
Majno and Joris (1995) define "oncosis" as a form of cell death accompanied by
cellular swelling, organelle swelling, blebbing, increased membrane permeability and
usually accompanied by karyolysis. It is thought to evolve within 24 hours to typical
necrosis and can be diagnosed by tests of permeability on whole cells, either in
suspension (by dye exclusion tests) or by electron microscopy (using a colloidal marker).
The mechanism of oncosis is supposed to be based on the failure of ionic pumps of the
plasma membrane (Majno and loris, 1995)
Interestingly, these authors also distinguish a third cell death modality, separate
from oncosis and apoptosis; for which the term "blebbing" has been proposed. Blebbing,
presumably a form of accidental cell death, is described as blister like fluid filled
structures, devoid of organelles. Blebs are thought to begin during the early stages of
ischemic damage and are found to be initially reversible. Large blebs may burst, and it
has been suggested that this may be the final blow 10 a dying cell (Majno and Joris,
1995).
The lerm necrosis derives from the Greek fleJerOS (dead) and 05;5 (condition),
meaning "deadness'". The term necrosis has been used for more than 2()(x) years to
describe "dead changes of tissue visible to the naked eye" (Majno and Joris, 1995). It has
more recently been defined as "death of tissue, usually as individual cells, groups of cells,
or in small areas", "or a phase characterized by the break up of organized structure and
function in the cell after it passes the point of no return during an acute cell injury"
(Mergner et 01., 1990). All the above definitions indicate that necrosis is the status of
death in cells or tissues, irrespective of the mechanism ofdeath. Within the framework of
classification of cell death proposed by Majno and Joris (1995), the necrotic step follows
either oncosis or apoptosis and thus can be denoted either as oncotic or apoptotic
"necrosis" respectively.
An identifying characteristic of lleCf05is is the morphological change that OCCUI1
when there is an increase in cell volume. This cellular swelling is caused by a change in
the osmotic pressure gradient, which is due to loss of control of ion influx allowing the
cell to take on more water (Samali et 01., 1996). As the cell volume increases, the
chromatin inside the cell takes on a more flocculated pattern with a subsequent loss of
plasma and organelle membrane integrity (Veda and Shah, 1994). This eventually leads
to cell rupture and the release of cellular components to the elClracellular space. The
consequence of cell lysis is the pathological effect these spillages have on the
neighbouring resident cells inducing catastrophic injury or even cell death (Ueda and
Shah, 1994; Kerr et 01., 1994). This massive cellular damage is known as an
"inflammatory response" (Ueda and Shah, 1994). DNA degradation of necrotic cells
happens later by proteases destroying histone (DNA associated proteins) (Darzynkiewicz
etal.,I997)
Darzynkiewicz et al. (1997), proposes the term "cell necrobiology" to refer to the
studies of events which occur during both aJXlptosis and oncosis, while another term "cell
necrology" refers to the postmonem events, defined by Majno and Joris (1995) as
necrosis. In contrast to apoptosis, which has been studied extensively, little is known
about characteristic features ofearly necrotic cells, which may serve as markers for their
identification (Darzynkiewicz et 01., 1997)
1.3. Regulation of Apoptosis
Apoptosis can be triggered by a wide variety of stimuli, including
chemotherapeutic drugs, ultraviolet light irradiation, heat shock, cytokines, oxidative
stress, growth factor deprivation, viral infections, genetic abnormalities, as well as
nonnal differentiation and development (Reed, 1998b). Moreover, the initiation of
apoptosis involves biochemical changes that might be unique to each apoptotic stimulus
(Ucker, 1997).
At least two apoptotic pathways leading to the execution of apoptosis have been
identified: a mitochondria-dependent pathway that is clearly governed by Bcl-2 family
proteins and a parallel pathway involving activation of upstream caspase-8, such as those
involved in Fas and TNF receptors signaling (Levy and Nelson, 2000).
Some cytoldnes, such as Fas ligand (FasL) and TNF-a, can bind to their receptors
on the plasma membrane, causing trimerization of their receptors and thereby activation
of an initiator caspase such as caspase-8 through interaction of the receptor with death
adaptor proteins such as FADD (Fas-associated death domain) or TRADD (TNF receptor
associated death domain) (Baker and Reddy, 1998; Nunez et ai., 1998). In addition, other
apoptotic stimuli, such as the anti-cancer therapeutic agent using
cisdiamminedichloropplatinum (Il) (cisplatin, CDDP), can cause mitochondria
dysfunction. Mitochondrial dysfunction includes a reduction in the mitochondrial
membrane potential, production of reactive oxygen species (ROS), opening of the
permeability transition pore (PTP) and the release of the intennembrane space protein.,
cytochrome c (see review Gross et 01., 1999). In response to cytochrome c binding, the
apoptotic proteinase activating factor-I (Apaf-I) can fonn a complex with and then
activate initiator caspase-9 (Li et 01., 1998; Zou ef aI., 1997).
Interrelationships probably exist between these two pathways within the cell
(Levy and Nelson, 2000). For example, Bid, a pro-apoptotic Bcl·2 family protein., is
cleaved into two fragments by caspase-8 in response to signaling by Fas or TNF receptor
The C·tenninal fragment of Bid then binds to mitochondria, thus initiates the
mitochondria-dependent pathway to apoptosis (Li et aI., 1998; Luo et aI., 1998).
The mitochondria dependent pathway, in response to a variety of exogenous
stimuli, communicates a death signal through modulation of genetically programmed
proteins. These mainly comprise of the Bcl-2 family proteins, many of which reside in
the inner and outer membrane of the mitochondria (Levy and Nelson, 2000)
1.3.1. The Bc:I-2 Gtnt Family
The initial discovery ofgen~directedcell death in Caenorhabditis elegalls fuelled
an intensive search for new genes exclusively involved in the regulation or execution of
cell death pathways (Bakshi et al., 1985; Cleary et aI., 1986). Many new cell death
regulators have been identified, and several gene families largely comprised of cell death
mediators have emerged. Much of our recent understanding concerning the molecular
regulation of cell death originates with the bcl-2 family (Tsujimoto et aI., 1985). The Bel-
2 gene family includes both positive (Bax, Bcl-Xs, Bad, Bik) and negative regulators of
apoptosis (Bcl-2, BcI-xL, Mcl-I) (Yang and Korsmeyer, 1996). Family members interact
to form homodimers and heterodimers with other related and non-related proteins. Cell
susceptibility to apoptosis is thought to be largely influenced by the relative ratios of pro-
apoptotic and anti-apoptotic Bel·} family members
The prototype of the family. Bcl-2 was originally cloned from the t(14:18)
translocation break-point associated with follicular lymphoma and was subsequently
identified as a negative regulator of apoptosis analogous to its homologue, ced-9 in C.
elega11S (Bakshi et aI., 1985; Cleary and Sklar. 1985; Tsujimoto et aI., 1985; Cleary et al.,
1986; Tsujimoto and Croce, 1986). The Bcl-2 gene maps to 18q21 and is expressed at
inappropriately high levels in those lymphomas possessing the t(14;18). Over-expression
of BcI·2 has been shown to protect a variety of cell lines from apoptosis induced by a
broad range of signals, including gromh factor deprivation, UV irradiation, oxidative
stress, cytotoxic drugs and heat shock (Yang and Korsmeyer. 1996). The ability of BcI-2
to protect against such a broad range of inducing signals suggests that the biochemical
functions of this family fonn a late control point prior to the execution stage of apoptosis.
Bd-2 does not protect against all death inducing signals, for example apoptosis induced
by cytotoxic T lymphocytes (Vaux et at., 1992), suggesting the presence of alternative
pathways which circumvent this control point
Members of the Bcl-2 family of proteins share two conserved regions which are
referred to as BHI and BH2 (Oltvai et al., 1993; Yin et aI., 1994; Yin et aI., 1995) or
domains Band C (Tanaka etal., 1993; Hanada et al., 1995), respectively. Both BHI and
BH2 domains appear to be important for mediating the physical interaction between BcI-
2 and other family members, most notably the dominantly acting death accelerator, Bax
(Korsmeyer etal., 1993; Vin et al., 1994; Yang etat., 1995; Hanada et at., 1995; Sedlak
et al., 1995). The BH1 and 8H2 domains do not appear to mediate Bc1·2
homodimerization. Rather, formation of Bcl-2 homodimers appears to be mediated by a
conserved NH2 terminal region and referred to as domain A (Hanada et al., 1995). II has
been speculated that the ability of BcI-2 to suppress cell death is a function of the relative
proportion of Bcl-2 h9modimers and BcI-2fBax heterodimers (Korsmeyer et aI., 1993;
Yang et aI., 1995).
1.3.1.1. Bd-2
The human Bc1·2 gene consists of three exons and spans approximately 230 kilo
bases (kb) (Seto et al., 1988). The Bcl-2 open reading frame spans exons 2 and 3 and
encodes a 25 kilo-dalton (kDa) integral membrane protein (Seto el al., 1988).
The human Bcl-2 consists of 239 amino acids and includes a 19-amino acid
hydrophobic carboxy-terminal end which functions as a membrane anchor (Hockenbery
et af., 1990). The transmembrane domain may serve to optimize BcI-2 function (Nguyen
et aI., 1993; Nguyen et al., 1994), but it has been shown in deletion mutants that cell
death suppression by Bcl-2 can be maintained in Ihe absence of the membrane-spanning
domain (Hockenbery er a/., 1993; Bomer et at., 1994;). Immunoelectron microscopic
studies have demonstrated that the Bcl-2 protein preferentially localizes within the
mitochondria at points where the inner and outer mitochondrial membranes are closely
opposed to the endoplasmic reticulum and the nuclear envelope (Krajewski et al., 1993;
Akao et at., 1994; Lithgowetal., 1994).
Although Bcl·2 is subject to both tissue specific and developmental regulation,
linle is known about the molecular mechanisms of its funetions. Recent evidence
suggests that Bcl-2 may modulate intracellular signalling events associated with cell
death induction. In this regard, a sustained modest increase in intracellular Ca++ is
frequently implicated as an important cell death signalling mechanism (Nicotera et ai"
1994). This Ca..... signalling results initially from depletion of Ca·- from the endoplasmic
reticulum followed by the influx of Ca..... across the cytoplasmic membrane. Bc1-2 ltas
been shown to inhibit depletion of Ca+-> from the endoplasmic reticulum and thereby
prevent capacitative Ca- entry into the cell (Lam ef a/., 1994; Marin ef at., 1996)
Additionally, Bcl-2 also appears to actively inhibit the intranuclear accumulation ofCa-
following cell death induction (Marin et a/., 1996).
Reactive oxygen species have also been implicated in Ihe mediation of apoptotic
cell death in some experimental systems. In this regard, Bc1-2 has been shown to inhibit
the generation of reactive oxygen species or to significantly impede downstream
oxidative damage resulting from the radicals once they have been generated (Korsmeyer
ef at., 1993; Kane ef at., 1993; Akao et ai., 1994). However, it ltas also been
demonstrated that Bcl-2 can inhibit cell death induction under conditions, which preclude
the formation of reactive oxygen species (Jacobson and Raff, 1995). Therefore, the
ability of Bc1·2 to protect against the damaging effects of free radicals does not appear to
account for Bc1-2 cell death suppression completely (Jacobson and Raff, 1995; Shimizu
etaJ.,1995).
1.3.1.1.B8:I
The Bc1·2 associated protein, Bax, was first identified as a 21-kDa protein that
coimmunoprecipitates with Bc1-2 (Oltvai et a/., 1993). Bax is a six exon, 4.5-kb gene.
Bax shares 21 % identity and 43% similarity with Bel-2. The most conserved regions
between the two molecules are the BHl and BHZ domains encoded by exons 4 and 5,
respectively. The junction of Sax exons 5 and 6 is identical to the exon 2 and 3 junction
in the Bcl-2 gene (Oltvai eta/., 1993).
A complex pattern of alternative RNA splicing predicts three different splice
variants ofBax (Apte et al., 1995). Bax-a has a 1.0 kb RNA that encodes a 192-amino
acid, 21 kDa protein with a transmembrane hydrophobic region. Bax-p has a 1.5 kb RNA
that encodes a 218-amino acid, 24 kDa protein that lacks tlte transmembrane segment and
is presumably a cytosolic form of Bax. Bax-y lacks the 53 base pair (bp) exon 2, and
consequently the reading frame in exon 3 is shifted. More recently, a Bax-J cDNA clone
was isolated which results from splicing of exon 2 to exon 4 and retains tlte carboxy-
tenninal transmembrane anchor as well as the BHI and BID domains (Apte et aI., 1995).
The functional significance of these individual Bax variants is, in large pan, unknown
BcI·2 family members function in part through protein-protein interactions and
susceptibility of cells to apoptosis is determined by multiple competing dimerizations in
which Bax is a common panner e.g. Bel·2/Bax or Bcl·xtfBax (McDonnel et aI., 1996).
"
Enforced Bax expression may overcome Bcl-2 mediated cell death suppression
and result in accelerated apoplotic cell death following a death inducing stimulus
(Nguyen et aJ., 1993). It has been suggested that the relative amounts of BcI·2 and Bax
may be considered as a "rheostat" which determines the susceptibility of a cell to undergo
apoplosis (Korsmeyer el aJ., 1993). According to this scheme, when Bcl-2 is in excess,
Bcl-2 homodimers predominate and protect the cell from apoptosis. Conversely, when
Bax is in excess, Bax homodimers predominate, and the cell becomes susceptible to
apoptosis following exposure to an apoptOlic signal (Korsmeyer et al., 1993)
Immunohistochemical analysis ofBax protein tissue distribution showed that Bax
is more expressed compared with BcI·2 (Krajewski er aJ., 1994). Although there is some
overlap between Bax and Bcl-2 proteins their subcellular distribution is non-overlapping
within several tissues. For example, Bax immuno staining was located in the base of the
crypts of the small intestinal mucosa and surface epithelial cells in the colon. In contrast,
Bcl-2 protein staining was mainly detected in the absorptive epithelium of the small
intestine and the base of the colonic crypts. In the prostate, strong Bax immunostaining
was detected in the androgen-dependent secretory epithelium, whereas BcI-2 was only
expressed in the androgen-independent basal cells (Krajewski et aI., 1994). Differential
expression was also seen in the lymph nodes, where Bax is expressed in the germinal
center lymphocytes known to exhibit high levels of apoptosis, while Bcl-2 expression
was primarily by the interfollicular lymphocytes (Krajewski et aI., 1994)
The regulation of cell death displays lineage specific abberations in Bax knockout
mice (Knudson et aI., 1995). The thymuses and spleens of Bax deficient mice were
hyperplastic, secondary to an accumulation of T and B lymphocytes. However, the
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ovaries contained unusual atretic follicles with excess granulosa cells. Additionally, the
male Bax knockout mice were infertile secondary to disorden of the seminiferous
tubules, accumulation of atypical premeiotic germ cells, and absence of mature haploid
spermatocytes. These alterations were accompanied by multinucleated giant cells and
dysplastic changes. Therefore, developmental absence of Sax protein can result in either
hyperplasia or hypoplasia in a cell type·dependent manner (Knudson ef a/., 1995).
The expression of Bax can be modulated at the transcriptional level by p53
(Miyashita and Reed, 1995). p53 is a sequence-specific DNA-binding protein, and known
targets ofp53 include genes associated with growth control, cell cycle checkpoints, DNA
repair, and apoptosis (reviewed by Amundson et a/., 1998). The Ml myeloid leukemia
cell line transfected with a temperature-sensitive p53 mutant expression vector exhibits
rapid increase in Sax mRNA within 4 h of shifting cells to the permissive temperature
(Zhan et al., 1994). Bax mRNA was also upregulated following apoptosis induction by
ionizing radiation but only in cell lines that possess wild-type p53 (Zhan el aJ., 1994)
The Sax gene promoter was shown to contain four p53-binding sites (Miyashita and
Reed, 1995). These sites could be specifically transcriptionally transactivated by p53 in
reporter plasmids driven by the Bax promoter. Together, these data suggest that Sax may
function as a primary response gene in a p53-reguIated apoptotic pathway (Miyashita and
Reed, 1995). However, p53-independent apoptosis pathways were also found to exist
(Strasser et a/., 1994).
Recent evidence suggests that Bax may playa role as a tumour suppressor. For
example, Bax·a is expressed at high levels in nonnal breast tissue and is undetectable or
expressed at low levels in breast cancers (Bargoll et a/. , J995). Futhermore, reduced Sax
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expression was associated with poor response to combination chemotherapy and shorter
survival in women with metastic breast cancer. Direct experimental findings concerning
the potential tumour suppressor activity of Bax has, however, not yet been reported
(Bargou et aI., 1995).
It has been suggested that Bax, which contains a C-terminal transmembrane
domain, displays regulated movement between cytosolic and mitochondrial
compartments. In the cytosol of healthy cells the transmembrane domain of Bax is
masked; assuming a latent confonnation. Various apoptotic stimuli cause Bax to undergo
a conformational change; the translocation to and insertion into mitochondria
membranes. The nature of the signal that controls Sax activation remains largely unclear,
though changes in cellular pH is thought to playa role (Reed, 2000).
1.4. Biocbemical sequelae ofapoptosis: Caspases
The regulation system of apoptosis in response to various stimuli involves the
presence of at least two distinct checkpoints: one controlled by the BcI-2IBax family of
proteins, another by the cysteine and possibly by the serine proteases (Darzynkiewicz et
al., 1997). Through several oncogenes and tumour suppressor genes, this system interacts
with the machinery regulating cell proliferation and DNA repair prOteases
(Darzynkiewicz el aI., 1997). The programmed cell death pathway has been studied most
successfully in the nematode C. elegans (Ellis and Horvitz, 1986), and it is from an
appreciation of the components of this primitive pathway that the field derives much of
the framework. The ced-3 gene was found to be a key regulator of apoptosis in these
nematodes. Humans contain at least ten homologs, complicating the assessment of their
individual functions (Allen et at., 1998)
Apoptosis triggered by all stimuli has in common the ablility to induce activation
of a family of cysteine proteases called caspases, which cleave a variety of specific
protein substrates (Cryns and Yuan, 1998; Nunez el aJ., 1998). Caspases implement cell
death as the execution arm for aJXlptosis (Nuftez el at., 1998). Caspases are important
components of cell death pathways, normally present in the cell as zymogens that require
proteolysis for activation of enzymatic activity. The mammalian caspases have been
divided into upstream initiator caspases and downstream effector caspases, based on their
sites of action in the proteolytic caspase cascade. Binding of initiator caspase precursors
to activator molecules appears to promote procaspase oligomerization and autoactivation
by enzymatic cleavage of the procaspase into fragments. Enzymatic activation of initiator
caspases leads to proteolytic activation of downstream effector caspases and then
cleavage ofa number of vital proteins, including JXlly(ADP-ribose} polymerase (pARP),
gelsolin, MEKK-I, and lamin (Cryns and Yuan, 1998). For example, expression of the
gelsolin cleavage product in multiple cell types caused the cells to round up, detach from
the plate, and undergo nuclear fragmentation (Kothakota et at., 1997).
The caspases can be divided into three subfamilies based on sequence similarity
and substrate specificity_ The ICE subfamily comprises caspases-l, 4,5 and II, the CPP-
32 (caspase-3) subfamily comprises caspases-3, 6, 7, 8, 9 and 10 and, to date, caspase-2
stands alone (Harvey and Kumar, 1998).
I'
1.4.1. The role of caspase-3 in apoptosis
The caspase-3- like subfamily is composed of caspase-3 and its closest
homologues caspases-6, 7, 8, 9 and 10, Caspase-3 was first cloned by Femandes-Alnemri
ef al. (Alnemri et aI., 1996), and shown to encode a 32 kDa cysteine protease
homologous to ced-3, caspase-I and caspase-2 that was capable of inducing apoptosis
when overexpressed in insect cells. By sequence comparison with ICE, the active enzyme
was thought to consist of sub units 20 kDa and 11 kDa in size, the only major difference
between the sequences being the absence of a long amino-tenninal pro-domain in
caspase-3. Caspase-3 was subsequently identified as the protease responsible for cleaving
poly(ADP-ribose) polymerase (pARP) (Allen et af., 1998). PARP is a nuclear enzyme
involved in DNA repair and was one of the first cellular substrates shown to be cleaved in
apoptotic ceJls (Allen et aI., 1998). It has been recently demonstrated that caspase-3
activates the endonuclease called caspase-activated Dnase (CAD), which is responsible
for the fragmentation of DNA, by specifically cleaving and inactivating the inhibitor of
CAD (ICADIDFF45) (Liu el aJ., 1997; Enari et af., 1998; Sakahira ef af., 1998)
1.5. Multidrug Resistance (MDR)
The challenge of clinical resistance to chemotherapeutics was recognized soon
after introduction of the first anti-neoplastics. Drug resistance is now one of the major
obstacles limiting the success of conventional anti-neoplastics, Biological mechanisms
contributing to drug resistance may be present de novo and relate to inherent cellular
features or may arise after exposure to anti.neoplastics (Szakacs et af., 1998). Intrinsic
drug resistance is believed to be responsible for the relatively poor response to
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chemotherapy observed in patients with pancreatic, renal, and non-small cell lung cancer
(patel and Rothenberg, 1994). Cancers such as breast, ovarian, small cell lung cancer, the
acute leukemias, and lymphomas, although associated with high initial response rates,
have limited curative potential due to the acquisition of cellular mechanisms of drug
resistance (patel and Rothenberg, 1994). Pre.clinical investigations support a complex
and redundant network of resistance mechanisms that include decreased intracellular drug
accumulation, intracellular de-toltification, altered nuclear drug targets, impaired
transduction of growth arrest signals and inherent cytokinetic resistance (Kellen, 1993)
Many of these mechanisms represent physiological functions conserved in their
malignant counterparts, and correlative studies indicate that some of these mechanisms
may contribute to clinical chemotherapy resistance (Chaudhary and Robinson, 1991).
So far, three separate forms of MDR have been characterized in detail: classical
MDR, non-Pgp MDR and atypical MDR. Although all three MDR phentypes have much
in common with respect to cross-resistance patterns, the underlying mechanisms certainly
differ (Nooter and Stoter, 1996)
1.5.1. Classical MDR
The classical MDR cell phenotype is characterized by a reduced ability to
accumulate drugs, as compared to the parent cell lines, being most likely the main cause
for the multidrug resistance, The reduced drug accumulation in classical MDR is due to
activity of an energy-dependent unidirectional drug-emux pump with broad substrate
specificity. The MDR drug pump is composed ofa transmembrane glycoprotein (P-gp)
with a molecular weight of 170 kDa (Chen el al., 1986), and is encoded by the so-called
multidrug resistance gene. The glycoprotein is generally called P-glycoprotein, P
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indicating permeability because it was originally thought that the glycoprotein regulated
cellular permeability (Juliano and Ling, 1976). P-glycoproteins are about 1280 amino
acids long, and are composed of two homologous halves; each half consists of six
predicted transmembrane domains and intracellular loop with a consensus ATP-binding
motif(Chen et at., 1986). This architecture has been associated with both active transport
and passive ion channel activities (Ames and Lecar, 1992). P-glycoproteins are post·
translationally modified by glycosylation and phophorylation. Glycosylation of p.
glycoprotein is not required for its multidrug transport function (Schinkel et aI., 1993),
However, it has been suggested that N-glycosylation may contribute to correct folding,
proper routing and stabilization of the molecule. P-glycoprotein uses energy in the form
of ATP to transport drugs through a channel fonned by the transmembrane segments
(Horio et aI., 1988), It is assumed that the P-glycoprotein drug pump might act by
extracting drug from the membrane at its external face, and its internal face by two
related but functionally separable processes (Stein et at., 1994). It has been a maner of
debate as to whether the drug accumulation defect in classical MDR cells is due to
decreased drug influx or an increased drug efflux (Stein el at., 1994)
U5.t.t. P.glyc::oprotein exprtnion in normal titsues and tumours
P-glycoprotein is mainly found in specialized epithelial cells with secretory or
excretory functions. In the liver, P-glycoprotein (P-gp) is present on the billiary surface
of hepatocytes and small billiary duetules, in the pancreas on the luminal surface of the
epithelial cells of small ductules., and in the kidney on the brush border of the proximal
tubules (Thiebaut el al.. 1987). The colon and jejunum both show high levels ofP-gp on
the luminal surfaces of the mucosa. P-gp expression is also found in other specialized
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epithelial cells such as sweat glands of the skin, cells lining in the trachea and major
bronchi in the lung, glandular epithelial cells of the prostate, breast endometrium and
thyroid, acinar cells of the pancreas, trophoblasts in the placenta (van der Valk et aI.,
1990). P-gp expression is also detectable in hemopoietic cells in bone marrow and
peripheral blood (Chaudhary and Robinson, 1991), and in capillary endothelial cells in
human brain and testis (Cordon-Cardo et aI., 1990)
Expression of MDRI gene has been detected in all tumour types, such as
carcinomas, sarcomas, leukemias and lymphomas (Goldstein er aI., 1989; Cordon-Cardo
et aI., 1990; Chan et aI., 1991; Center, 1993). Tumours that developed from tissues
normally expressing high MDRI levels, e.g. colon, liver, kidney, adrenal and pancreas,
also have relatively high levels of MDRI expression. Clinically, these tumours are all
intrinsically drug resistant, i.e. have a very low response rate to chemotherapy. Other
tumours occasionally have elevated MDR I expression levels, but quite often show a lack
of such expression. This group contains, among others, hematological malignancies,
neuroblastomas, soft tissue sarcomas and cancer of the breast, ovary, lung and bladder. In
general these tumours respond better to chemotherapy than the previous group, and even
complete responses can be achieved. Unfortunately, a high percentage of patients relapse
and become resistant to chemotherapy (Bosch and Croop, 1996)
15 1 2, Clinical relevance of the dankal MDR phenotype
After the discovery that the P-glycoprotein molecule can be expressed in human
tumors, clinical trials have been initiated with the aim to block the P-glycoprotein drug
pump, and in that way make anti-cancer drugs more effective (Raderer and Scheithauer,
1993), Clinical modulation studies have been performed in cancers with an intrinsic
classical MDR phenotype, like colon and kidney cancer as well as in cancers that have
acquired the classical MDR phenotype during the course of the therapy as is the case of
some hematological malignAncies (Jachez eta/., 1993; Keller et al., 1992).
1.6. Sanguinarine
The Quaternary benzo[c]phenanthridine alkaloid sanguinarine occur in several
genera of the families Papaveraceae, Berberidaceae, Fumariaceae and less abundantly in
Menispermaceae, Ranunculaceae, Rutaceae and Sapindaceae (Schmeller et al., 1997). An
alkaloid is physiologically active, nitrogen containing low molecular weight, base
compound extracted from plant material (pauli and Kutchan, 1998). Sanguinarine (13-
methyl[l,3]benzodioxolo[S,6-c]-1.3-dioxolo[4,S-I]phenanthridinium) is a commercial
drug derived from the root of SaIlJPlillaria canadensis (bloodroot) and Chdidollillm
Majus L. (Greater Celandine) (lenfeld et al., 198 J).
The iminium charge on the benzo[c]phenamhridine ring seem to be necessary for
their biological action (Y\-es et al., 1993; Arisava et 01., 1984; Monroe et al., 1987). The
iminium bond of any quaternary benzo[c]phenanthridine alkaloid is highly Sl.lsceptible to
nucleophilic anack (Yves er al., 1993).
The pharmacological activities of sanguinarine are several. Many alkaloids of the
benzo[c]phenanthridine family, including sanguinarine, display anti-tumour propenies
(Simeon et at., 1989). Apan from its anti-tumour propenies, Sanguinarine shows
antimicrobial activity against a wide variety of microorganisms, which include bacteria,
fungi and protozoa. Sanguinarine acts as both a bacteriostatic agent and a bactericide to
major gram-positive and gram-negative bacteria (Odebiyi and Sofowora, 1979;
Vichkanova et aI., 1969; Dzin and Sacransky, 1985). Sanguinarine possess good
antifungal activity against Candida alhicans and the dennatophytes of trycophyton
species Epidennophytoll floccosum, Microsporum canis, and Aspergillus fumigatus
(Hejmankova et aI., 1984). The anti-inflammatory effects of this drug have also been well
documented (Lenfeld et aI., 1981). The biochemical activities of sanguinarine includes
the inhibition of protein kinase C (lanin et aI., 1993; Gopalakrishna et al., 1990), NF.~;B
(nuclear transcription factor) (Chaturvedi et aJ., 1997), Na-/K- ATPase (Straub and
Carver, 1975; Seifen et aJ., 1979) and of tubulin assembly (Wolff and KnipJing, 1993)
By intercalation, sanguinarine forms a molecular complex with DNA, specifically
binding to regions rich in guanosine-cytosine (Sen and Maiti, 1994); this intercalation, at
least in part, may contribute towards tumour cell killing. Sanguinarine is at present an
ingredient in many over-the-counter products including toothpaste, mouthwash, cough
and cold remedies and homeopathic preparations, for its anti-bacterial and anti-fungal
properties (Frankos et aI., 1990).
1.7. Objectives
From the foregoing review of the literature, it can be concluded that two major
forms of cell death are identified: apoptosis and accidental cell death, and that following
cell death, both types undergo postmonem changes col1ectively termed "necrosis". In
addition, the regulation of apoptosis and the role of caspases were discussed. An
introduction to the benzophenanthridine alkaloid sanguinarine, and to features of the
classical MDR phenomenon was also provided.
As previously stated, the benzophenanthridine alkaloid sanguinarine has
anticancer potential through induction of cell death. Studies in our laboratory have
demonstrated that K562 cells, when exposed to sanguinarine for two hours at
concentrations of 1.5 Ilglml and 12.5 Ilglml, displayed two different morphologies
corresponding to two different modalities of cell death. At 1.5 J.lglml, cells displayed the
formation of apoptotic bodies over the entire cell surface, consistent with the current
criteria ofapoptosis or programmed cell death (PCD). At concentrations of 12.5 Ilglml,
cells displayed the morphology of large blister formation (commonly a single blister and
usually not more than two) or "blister cell death" (BCD). Several repons in the literature
have found K562 cells to be rather resistant to the induction of apoptosis (Kobayashi et
a/., 1998); sanguinarine, on the contrary, was able to effectively overcome this resistance
Previous observalions in our laboratory of apoptosis or programmed cell dealh (PCD) and
blister cell death (BCD) induced by the semisynthetic benzophenanthridine alkaloid
derivative Ukrain™ in K562 cells was termed "bimodal cell death" (BMCD) (Liepins et
01., 1996). My hypothesis is that apoPlosis and BCD are two different cell death
processes, and the efficacy of anti-cancer drugs depend on the execution of both these
processes; also, BCD, like apoptosis, may be genetically controlled.
The molecular mechanisms of cell death and its role in chemotherapy, and drug
resistance are poorly understood. A thorough understanding of these mechanisms is
indispensable for the search and development of novel chemotherapeutic agents (Reed et
al., 1994; Reed, 1995). Accordingly, the general objective of my study was to gain
insight into the mechanisms of tumour cell killing by sanguinarine.
Recently, the semisynthetic benzophenanthridine alkaloid derivative Ukrain™
(NSC--631570), has shown to have efficacy towards human tumours (Susak el af., 1996;
Brzoska et al., 1996), and is widely used as an unconventional mode of treatment (see
entire issue of Drugs under Experimental and Clinical Research suppl. to vol. xxii, 1996).
Ukrain was screened in vitro by the National Cancer Institute (NCt Development
Therapeutics Program, USA), and found to have cytotoxic effects on their 60 human
tumour cell lines (Liepins et ol., 1996). These facts on Ukrain™ prompted us to
investigate the anti-cancer potential of another benzophenanthridine alkaloid-
sanguinarine. Based on the model of sanguinarine induced bimodal cell death (i.e. PCD
and BCD), my specific objectives were as follow:
I) Characterization of PCD (apoptosis) and BCD (blister cell death) induced by
sanguinarine, in the form of a comparative study at the cellular level, using the low
Bc1·2 expressing K562 erythroleukemia cells (Kobayashi et al., 1998) and the high
Bc1-2 expressing 1M1 pre-B lymphoblastic cells (Samson el aI., 1996) (the low and
high Bc1-2 expression in K562 and 1Ml cells respectively, was also confirmed in our
laboratory using western blotting techniques). K562 and 1M I cells were chosen based
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on their respective Bcl-2 status. Thus, in addition to the characterization of
sanguinarine-induced PCD and BCD, this comparative study also allowed to
determine the importance of BcI·2 in the susceptibility/resistance of tumour cells to
sanguinarine. Methods used for this purpose included, light microscopy, electron
microscopy, 'ICr release, propidium iodide exclusion, trypan blue exclusion, annexin
V binding and terminal deoxynucleotidyl transferase (TdT) end labelling
2) Characterization of PCD and BCD induced by sanguinarine, in the form of a
comparative study at the molecular level, using the low BcI·2 expressing K562 cells
and the high BcI·2 expressing 1Ml cells. The methodologies used for this purpose
were western blotting technology and cDNA expression array studies. The role of the
BcI-2 family and caspases were analyzed
3) Measuring Bcl.2, Bax and NF-J,"B (nuclear transcription factor) protein levels in
K562 and 1M1 cells using immunofluorescence·flow cytometric analysis in PCD and
BCD induced by sanguinarine. This study also enables the confirmation of results
obtained from western blotting
4) Studying p.g1ycoprotein expression in the multidrug resistant CEM-VLB 1000 cell
line and in its wild type counterpart CEM.T4, and characterization ofPCD and BCD
induced by sanguinarine at the cellular and molecular levels in both these cell lines
This study also enables, first, to observe the effects of sanguinarine in a cell system
different to that of the above (i.e. K562 vs 1M! cells) and second, to evaluate the
effects of sanguinarine in a Pgp positive multidrug-resistant (MDR) cell!ine.
It is hoped that this work may shed further light on the cellular and molecular
parameters of peD and BCD induced by sanguinarine. and to assess the roles played by
"
Bcl-2 and Pgp in sanguinarine-induced bimodal cell death. Hence, it is felt that this study
would reveal, at least in part, the anti-cancer potential of sanguinarine, and discover the
mechanisms by which it may induce tumour cell killing
1.8. Co-authorship Statement
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papers. The work done by each of the four authors is as follow·
(I) First author- the entire work concerning identification and design of the research
proposal, practical aspects of the research, data analysis and manuscript preparation.
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Summary
Our previous studies with the low Bcl-2 expressing K562 cells have shown that,
when treated with the pUlative anti-cancer drug sanguinarine, concentrations of 1.5 ).lg/ml
induced the morphology of apoptosis or programmed cell death (PCD), while
concentrations of 12.5 Ilg/ml induced a morphology of blister formation or blister cell
death (BCD). To elucidate the possible role of Bcl·2 in this dual cell death modality
induced by sanguinarine, K562 and the high Bcl-2 expressing JMl cells were treated with
sanguinarine concentrations of 1.5 IIg/ml and 12.5 ).lg/ml respectively, and multiple
parameters of their effects were studied using light and electron microscopy, terminal
deoxynucleotidyl transferase (TdT) end-labeling, !ICr release, trypan blue exclusion,
propidium iodide exclusion and annexin V binding. In general, it was found that, while
K562 cells underwent PCD and BCD when treated with sanguinarine, JM 1 cells failed to
undergo either PCD or BCD under the same experimental conditions. Thus, the over-
expression of anti-apoptotic Bcl-2 may have prevented sanguinarine from inducing PCD
and BCD in 1Ml cells. These results indicate that, resistance ofIMI cells to the alkaloid
sanguinarine may have been due to an anti-BCD role played by Bcl-2, in addition to its
widely reported anti-apoplotic role
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Introduction
Sanguinarine (SA) is a quaternary benzophenamhridine alkaloid derived from the
root of the plant Chelidonium Majlls L or greater celandine (Lenfeld el aI., 1981).
Among its many useful properties, the potential as a potent anti-cancer agent figure
prominently (Ahmad et aI., 2000; Simeon et aI., 1989). Our previous studies have
demonstrated that K562 human erythroleukemia cells, when exposed to sanguinarine at
concentrations of 1.5 figlml and 12.5 figlml for two hours, displayed the morphologies of
two different modalities of cell death: at I.S Ilglml the classical morphology of apoptosis
or programmed cell death (peD) and at concentrations of 12.5 Ilglml, the morphology of
single blister formation or blister cell death (BCD) (Weerasinghe et aI., in press)
Previous observations in our laboratory of apoptosis or programmed cell death (PCD) and
blister cell death (BCD) induced by the semisynthetic benzophenanthridine alkaloid
derivative Ukrain™ in K562 cells was termed "bimodal cell death" (BMeD) (Liepins et
aI., 1996). Thus, this dual cell death modality induced by sanguinarine was also termed
"bimodal cell death" (BMCD).
Programmed cell death (PCD), or apoptosis is a physiologically active cell death
process, characterized by formation of apoptotic bodies, changes in membrane
permeability, and nuclear DNA condensation and fragmentation (Liepins, 1989; Liepins
and Bustamante, 1994). The latter event, i.e. intemucleosomal DNA fragmentation, may
not occur in some experimental systems (Liepins and Bustamante, 1994; Stewart, 1994),
although considered to be a hallmark of apoptosis (Arends er aI., 1990; Compton, 1992)
The deregulated expression of the anti-apoptotic Bcl-2 gene product was found to
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contribute to multistep neoplasia through the suppression of cell death, or apoptosis, in
transgenic mouse models (McDonnell et aI., 1996)
In order to assess the effects of the endogenous anti-apoptotic protein Bcl-2 in
sanguinarine induced bimodal cell death (BMCD) i.e. PCD and BCD, we chose the 1Ml
human pre-B cell lymphoblastic cell line, which constitutively expresses elevated Bcl-2
gene product (Samson el aI., 1996), and the low Bcl-2 expressing K562 human
erythroleukemia cel1line (Kobayashi et aI., 1998). Our flow cytometric studies (as shown
in the present study) and previous western blotting analysis have confirmed the high Bel·
2 expression in 1Ml cells and its low expression in K562 cells, respectively. Both cell
lines were studied in tenos of their susceptibility to sanguinarine induced bimodal cell
death (BMCO) in order to detenoine whether the elevated Bcl-2 gene product would
protect 1Ml cells from programmed cell death (PCD) and/or blister cell death (BCD)
Results showed that sanguinarine effectively induced apoptosis or programmed cell death
(PCD) and blister cell death (BCD) in K562 cells, whereas, 1Ml cells showed resistance
This report also attempts to define a role (albeit a preliminary one) for BCD as a novel
form of cell death and to discuss its relevance in Bcl-2 associated chemoresislance
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Materials and Metbods
Cells and tell culture
The K562 erythroleukemia and 1MI pre-B cell lymphoblastic cell lines were
purchased from ATCC (Rockville, MD, USA) and were routinely maintained as cell
suspensions in RPMI·I640 medium supplemented with 10% fetal calf serum and L·
glutamine in a humidified atmosphere containing 5% CO2 at 3T'C. All experiments were
performed with K562 and JMI cells during their exponential phase of growth
Sanguinarine treatment
Sanguinarine HCI (Sigma Chemical Co.• St. Louis. MO) was dissolved in distilled
water to a concentration of 1.0 mg/ml. Serial dilutions were carried out (shonly before in
vitro use), with tissue culture medium [RPMl.1640 + 10% fetal bovine serum (FBS)]
Sanguinarine was serially diluted in RPMI + 10% FBS to give a concentration
range of 25 I!g/ml to 0.19 I!g/ml (8 dilutions) in flat bottom 24 well plates. Triplicate
wells of each drug concentration was prepared and aliquots of IxlO6 cells (K562 and
1MI) per well were added. These tissue cuilure plates were subsequently incubated at 3t
C/5% CO2 for two hours
Light micrnscopy
Cells treated with sanguinarine were studied and quantitated by light microscopy
The key morphological criterion for the detection of apoptosis was the formation of
apoptotic bodies and the key criterion for blister cell death was the formation of cell
surface blisters
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Electron microscopy
Cells were fixed with 2% glutaraldehyde, post fixed in I% osmium tetroxide,
dehydrated through a series of ethanols and embedded in TAAB 812 epoxy resin. Semi
thin (0.5 IJ-m) sections were cut axially, through all layers of each pellet to select areas for
ultramicrotomy. Ultra thin sections were stained with lead citrate and 300ill a1choholic
uranyl acetate and then examined in a JEOL loo-Cx electron microscope
Trypan blue assay
The vital dye, trypan blue, is excluded from putative live cells with intact plasma
membranes (O'Brien et aI., 1997; Zhang et aI., 1990). The changes in membrane
permeability in K562 and 1MI cells which were exposed to sanguinarine treatment and
untreated controls, were evaluated in triplicate using flat bottom 96 well plates at 2xl04
cells per well after 2 hours of incubation at 37"C. The exclusion of trypan blue (0.2%)
was used as an indicator of the number of live cells. After 10 minutes of incubation with
the dye, the number of trypan blue excluding cells was counted using a hemocytometer
The exclusion oftrypan blue was used as an indicator of the number of live cells.
Propidium iodide assay
This cell viability assay is based on the exclusion of the fluorochrome, propidium
iodide (Schmid et aI., 1994) by the cell membrane. K562 and 1Ml cells treated with
sanguinarine were evaluated for cell viability in triplicate in 96 flat bottom wen plates at
2xl04 cells per well and incubated for 2 hrs at 37"C. Thereafter, PI (5,uglml in PBS) was
added after cells were washed in PBS. After 10 minutes of incubation with the dye, the
number of PI excluding cells was quantitated by hemocytometer using fluorescence
microscopy.
J2
~ICr release assay
Cell injury was evaluated by Nal1cr04 release assay (Liepins, 1983; Liepins et
al., 1996). 2xlO~ cells from each cell line were labeled with 200 fJ.Ci of Nal lcr04 and
incubated for 90 minutes in a humidified incubator at 31'C15% CO2. Cells were washed
three times with PBS + 2% FCS in order to remove unincorporated Na2'ICr04.
Specific ~ICr release of K562 and 1MI cells exposed to sanguinarine treatment
and of untreated controls were evaluated using 96 V bottom well plates in duplicate at
2xlO4 cells per well, after two hours incubation at 37"C. The percentage of llCr release
was evaluated by the following formula
% Specific 'ICr release: ~~~:u:~~;nr~~~:~e -_~;;~~:~:u: ~e\::: x 100
Spontaneous 'ICr release is the amount of stCr released by cells in the absence of the
drug. Maximum 'ICrrelease is the 'ICrreleased by exposing the cells to IN HCl
F1uorescein·conjugated annexin V binding assay
After treatment with sanguinarine concentrations that induce PCD and BCD,
K562 and 1MI cells (lxI06 cells) were washed with PBS and incubated with annexin V
fluorescein isothiocyanate (FITC) conjugate and propidium iodide (PI) utilizing an
annexin V Fluos staining kit (Boehringer Mannheim Corp.). After labeling, cells were
resuspended in binding buffer and analyzed using flow cytometry. FIre-fluorescence
was measured at 530-545 nm and fluorescence of DNA-PI complexes at 575-606 nm
Cell debris was excluded from analysis by appropriate forward light scatter threshold
setting (Leist et a!., 1997).
lJ
Terminal deo:lynuc:leotidyl transferase (TdT) end-labeling assay
Specific 3'-hydroxyl ends of DNA fragments generated by endonuc1ease-
mediated apoPlosis are preferentially repaired by terminal deoxynuc1eotidyl transferase
(TdT) (Gavrieli et aI., 1992). The TdT mediated nick end labeling assay has been
developed to label these strand-breaks with streplovidin-horseradish peroxidase
conjugated nucleolides followed by the addition of a substrate (TBL).
After sanguinarine treatment, cells were removed from individual wells, washed
in PBS and fixed in 10"/0 neutral buffered formaldehyde for 10 minutes. Cells were
resuspended in 80"!G ethanol at lxl06 cells per ml. 50,000 cens were placed onto an
electrostatically treated glass slide and air dried at room temperature. Cells were then
permeabilized with proteinase K (Gavrieli et aI., 1992). Cell samples were then incubated
for 60 minutes at 37°C in the presence and absence of exogenous TdT and streptavidin-
horseradish peroxidase conjugated dNTP (deoxynucleotide triphosphate), followed by the
substrate TBL according to the manufacturer's instructions (Sigma TACS T:-l In Situ
Apoptosis Detection Kit, 51. Louis, MO, USA). Cells were then examined and
photographed under phase microscopy and counted to determine the percentage of cells
with DNA nicking to total cells
Detection of intracellular sanguinarine using flow cytometry
The auto-fluorescent nature of sanguinarine was used to measure its intracellular
levels by quantitating the amount of fluorescence using a Becton Dickinson flow
cytometer. Subsequent to drug treatment, celts were washed 3 times and subjected to
flowcytometricanalysis
Flow cytomttric analysis of BcI·2 in K562 and .1M! cells
Flow cytometric analysis of Bcl-2 was carried out as described by Re et at
(1998). Briefly, after treatment with appropriate concentrations of sanguinarine, K562
and JMl cells were fixed with 70% ethanol for 20 minutes at 4°C. Cells were then
washed twice with PBS and permeabilized with 0.5% Triton X 100 (Sigma, St. Louis,
MO) in PBS for 10 minutes at 4°C. After three washings with PBS, cens were
resuspended in 10% goat serum for one hour at room temperature before adding anti-Bcl-
2 monoclonal antibody (I :50, Santa Cruz Biotechnology, CA), and incubated overnight at
4°C. The cells were then washed five times in PBS. Thereafter a polyclonal goat anti-
mouse (!:lOO) antibody conjugated to fluorescein (FlTC) was added to cells and
incubated for 30 minutes at 3fc. The cells were washed five limes and analyzed by
FACS (Becton-Dickinson, Palo Alto, CAl
Thereafter, the cells were gated for forward scatter (FSC) and side scatter (SSC)
in order to rule out cell aggregates and debris. The negative controls consisted of
identical secondary labeling without primary monoclonal antibody. The positive control
was the expression of the HSP·70 housekeeping protein, which was detected by the anti
HSP-70 monoclonal antibody (I: 100 Santa Cruz)
Statistical Analysis
The results are presented as means ± SE. Statistical analyses were performed
using the student's I test. Differences were considered significant when p< 0.05
"
Results
KS62 cells Ireated for 2 hrs with 1.5 ~gfml of sanguinarine at 3rC displayed
formation of apoptotic bodies in over 96% of cells., whereas JM I cells trwed under
similar conditions did not display the morphology of apoptosis (Figs. 2-lb and 2-le
respectivdy). K562 cells, trealed with sanguinarine concentrations of 12.5 ",glml
displa}'ed the morphology of single blister formation or blister cell death (BCD) in over
9QO/o of cells (Fig. 2-lc), whereas JMI cells subjected to the same experimental
conditions failed to undergo this morphological phenomenon (Fig. 2-\ f). Untreated
control K562 cells and 1Ml cells are shown in Figs. 2-la and 2-ld respectively
Electron microscopy of K562 cells exposed to concentrations of sanguinarine thai
induce apoptosis (1.5 ",gfml), showed the classic morphological changes, consisting of
formation of apoptotic bodies (containing organelles), chromatin condensation and
nuclear fragmentation (Fig. 2-2b). When treated with sanguinarine concentrations that
induce BCD (12.5 }!glmI), KS62 cells displayed single blister formation (devoid of
organelles), patchy chromatin condensation and an increase in cytoplasmic vacuolization
(Fig. 2-2c). JMI cells, on the other hand, failed to undergo either PCD or BCD as a result
of sanguinarine treatment (Fig. 2·2e and Fig. 2.2f, respectively). However, 1M1 cells
treated with sanguinarine displayed an absence of microvilli, which was the only
significant ultra-stuetural change noted (Figs. 2-2e & 2·2f).
The ·1lCr release assay, which is a universal assay ofimmuno-effector cell lysis of
tumor cells., was used to measure cell injury (Liepins et al., 1996). K562 cells showed
20±2.8% increase in specific 'ler release when treated with concentrations of
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sanguinarine that induce PCD and 400.5% at concentrations that induce BCD. 1MI cells
when treated with sanguinarine failed to show 'ICr release (Fig. 2-3A)
Results of trypan blue exclusion studies, to assess plasma membrane integrity,
showed that during PCD and BCD >88% ofK562 cells excluded trypan blue (Fig. 2-3B),
as did lMl cells treated with sanguinarine. Similarly, results of PI membrane
permeability studies also found> 90"1a of PCD and BCD of K562 cells and> 90% of
JMl cells treated with sanguinarine excluding PI (Fig. 2-3C)
The annexin-V-assay was utilized for the detection of cell surface membrane
phosphatidyl serine CPS) flip, which is known to be associated with apoptosis or PCD
(Leist et al., 1997). Sanguinarine induced apoptotic K562 cells showed 4516.1% of
annexin-V-positive cells, i.e. binding of annexin V to phosphatidyl serine on the outer
surface of the cell membrane. K562 cells which underwent BCD did not show significant
annexin-V-binding (16±2.4%). Also, 1MJ cells treated with sanguinarine and untreated
controls did not show the phosphatidyl serine (PS) flip (Fig.2.4)
DNA nicking in PCD and BCD of both cell lines was studied by the teoninal
deoxynucleotidyl transferase (TdT) end-labeling method. Results showed DNA nicking
in >85% ofK562 cells during PCD (Fig. 2.5b), Sanguinarine induced BCD in K562 cells
failed to show DNA nicking (Fig. 2-5c). DNA nicking was also absent in lMl cells
treated with sanguinarine and in control untreated cells (Figs. 2.5e, 2-5f, 2-5d and 2-5a)
Measurements of intracellular sanguinarine based on its auto-fluorescence showed
comparable levels in K562 and lM1 cells treated with concentrations of sanguinarine that
induced apoptosis (Figs. 2-6b and 2-6e, respectively). However, BCD of K562 cells
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showed higher levels of sanguinarine in comparison with JMI cells treated with the same
concentration of sanguinarine (Figs. 2-& and 2.-6f, respectively).
Both cell lines were examined for endogenous BcI-2 levels in untreated controls
and for possible changes in its expression after sanguinarine treatment utilizing
immunofluorescence-flow cytomctry. The percentage of untreated control K562 cells
expressing Bc!-2 was 3].88% while the percentage of untreated control 1M1 cells
expressing Bcl-2 was 76.750/. (Fig. 2-7).
"
Discussion
Apoptosis was originally recognized based on changes in cell morphology as
revealed by light and electron microscopy (Kerr et al., 1972; Wyllie el ai., 1992; Majno
and loris, 1995). Light and electron microscopic studies of K562 cells treated with
sanguinarine showed the typical morphology of apoplosis: formation of apoptotic bodies
and nuclear fragmentation. Other parameters of apoptosis in K562 cells treated with
sanguinarine comprised of an increase in specific 'ICr release denoting cell injury and a
positive annexin-V-assay showing the phosphatidyl serine flip. The tenninal
deoxynueleotidyl transferase (TdT) end-Iebeling assay show DNA nicking in >85% of
apoptotic cells. However, exclusion of trypan blue and propidium iodide by apoptotic
cells indicate plasma membrane integrity. The exclusion of these dyes by cells
undergoing apoptosis is widely reported in literature (O'Brien et ai., 1997; Zhang et al.,
1990). In contrast, 1M I cells treated with the concentration of sanguinarine that induce
apoplosis in K562 cells did not show the morphology or the other parameters
characteristic of apoptosis. These observations coupled with the higher expression of Bel-
2 in 1MI cells (as opposed to K562 cells) strongly suggests the anti-apoptotic role of Bel-
2 in sanguinarine induced apoptosis
Various reports in literature indicate that high expression of the anti-apoptotic
Bcl-2 protein is associated with poor response to chemotherapy (Nakata et ai., 1998;
Reed et aI., 1994). Results of the present study also indicate that Bel-2 may be
responsible for poor response to sanguinarine due to its anti-apoptotic nature.
Treatment of K562 cells with sanguinarine at concentrations of 12.5 Ilg/ml,
induced the morphology of blister (usually one but rarely two) fonnation in >9QO!o of
cells. Electron microscopical studies showed the blisters to be devoid of organelles. Other
features of BCD revealed by electron microscopy were the absence of nuclear
fragmentation and the presence of vacuolization and patchy chromatin condensation. The
present study showed an elevation in SICr release during BCD, higher than that of
apoplOsis, in K562 cells. BCD also showed the absence ofbolh DNA nicking and the PS
flip. However, it was shown that BCD excluded trypan blue and propidium iodide,
denoting intact permeability of the cell membrane
Necrosis does not indicate a form of cell death but refers to changes secondary to
cell death by any mechanism (Levin et 01., 1999; Majno and Joris, 1995). It is known that
early necrotic cells lose plasma membrane integrity, thus permitting the enlry oftrypan
blue and propidium iodide into the cell (O'Brien et aI., 1997). The exclusion of trypan
blue and PI by BCD indicate thaI it is not representative of early necrosis
Blister formation is at best, only sporadically reponed in literature (Liepins el aI.,
1996; Phelps et aI., 1989). The phenomenon of BCD may resemble the "blebbing"
described by Majno and Joris (Majno and Joris, 1995). Majno and Joris describes
blebbing as blister like, fluid filled structures, typically devoid of organelles, that arise
from the cell membrane and are apt 10 swell and burst. It is suggested that the mechanism
of blebbing may appear to depend on a disconnection between the cell membrane and the
underlying cytoskeleton (Majno and Joris, 1995; Phelps et aI., 1989). Trump et al. (1997)
and Trump and Berezesky (1992) associates blebbing with increases in concentration of
cytosolic Ca2+ rCa......)i and rearrangement of cytoske1etal proteins including filamentous
actin, although Lemasters et al. (1987) saw no change in concentration of cytosolic Ca2+
{Ca.....]; during blebbing
In contrast to K562 cells, 1M I cells treated with concentrations of sanguinarine
inducing BCD in K562 cells, failed to undergo the morphological changes associated
with BCD. Microscopy showed no significant changes in sanguinarine treated 1MI cells
ITom untreated controls. Furthermore, sanguinarine Ireated JMl cells failed to show the
PS flip as well as DNA nicking, and showed no changes in 51Cr release. On the basis of
these results, the anti-apoptotic Bc1-2 may be associated with inhibition of the cell death
processes ofapoptotis and BCD. Thus, Bcl-2 may also be anti-BCD in addition to being
anti-PCD. Evidence ofBcI-2 inhibiting the process of cytoplasmic blebbing has also been
reported in recent literature (Ferri et aI., 2000). Hence, the anti·apoptotic Bc1-2 may
further compound chemoresistance by additionally being anti-BCD in nature (at least,
this may hold true in the case of sanguinarine treatment). Further characterization of BCD
at the cellular and molecular levels might provide a new dimension to understanding the
mechanisms of cell death and chemoresistance.
The role of BCD in tumour cell killing could be studied utilizing flow cytometric
analysis by capitalizing on the fluorescent nature of sanguinarine itself. Sanguinarine
exercises its anti-cancer properties (Simeon et al., 1989), among other probable
mechanisms, by forming a molecular complex with DNA by intercalation. More
specifically, by binding to regions rich in guanosine-cytosine (Babich et aI., 1996; Sen
and Maiti, 1994). Fig. 2-6 show a flow cytometric study of sanguinarine auto-
fluorescence in K562 and JMI cells treated with the drug. BCD, induced in the low Bc1-2
expressing K562 cells (Fig. 2.6c), showed high levels (48.5%) of red auto-fluorescence
while high BcI-2 expressing JM I cells treated with the same concentration of
sanguinarine (Fig. 2-6f) showed reduced levels (8.3%). Fluorescence microscopy found
the presence of sanguinarine predominantly in the nucleus of cells (data not shown).
Literature suggests that the Bcl-2 protein is located on the nuclear membrane (and also on
the mitochondrial and endoplasmic reticulum membranes) (Reed, 1998). Hence, an
interesting assumption would be whether the nuclear membrane BcI·2 is associated with
preventing sanguinarine from entering the nucleus and thereby averting its intercalation
with cellular DNA. On the other hand, it was shown that the level ofaut().fluorescence in
PCD of K562 cells was comparable 10 those of 1M I cells treated with the same
concentration of sanguinarine. This points to the fact that, unlike in BCD, the intranuclear
level of sanguinarine during PCD may not be Bcl-2 dependent.
It is reponed that apoplosis is only rarely observed ill vivo and may not be the sole
cell death mechanism (Houghton, 1999)_ These findings emphasize the need to explore
new forms of cell death mechanisms and corroborates our assenion that, at least in the
case of sanguinarine, tumour cell dealh may also be induced by BCD- a hitherto less
understood fonn of cell death. Sanguinarine induced bimodal cell death (BMCD) may
seNe as a unique model for the stUdy of apoptosis and BCD (i.e. blebbing). Funhamore,
Ihis model facilitates bener comparative analysis of both modalities of cell death, as they
are induced in one and the same experimental system.
Figure 2-1: Light micrographs (original magnification- x282) of K562 and 1Ml cells
treated with sanguinarine. Apoptosis (b) and blister cell death (c) in K562 cells treated
with sanguinarine at 1.5 Jlg/ml and 12.5 J.ig/ml respectively for 2 hrs. JM1 cells, which
express high endogenous levels of Bc1-2, are resistant to the induction of apoptosis (e)
and blister cell death (f) at the corresponding sanguinarine concentrations. Control
untreated K562 and JMI cells are shown in figs. (a) and (d) respectively.
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~: Electron micrographs (scale bar shown in respective figure) show control (a)
apoptosis (b) and blister cell death (c) in K562 cells induced by treatment with
sanguinarine 1.5 Ilg/ml and 12.5 Ilg/ml respectively for 2 hours. Also shown are, control
JMt cells (d), 1MI cells treated with sanguinarine 1.5 Ilg/ml (e) and 1M1 cells treated
with sanguinarine 12.5 Ilg/ml (f). Fig. (0) (PCD ofK562 cells) show apoptotic bodies,
nuclear fragmentation and chromatin condensation while fig. (c) (BCD of K562 cells)
show blister formation, patchy chromatin condensation and an increase in vacuolization.
As shown in figs. (e) and (f), the only ultra-structural change noted in 1Ml cells when
treated with sanguinarine (compared with control untreated cells) is the absence of
microvilli.
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~: Changes in membrane penneability to 31Cr in K562 and JMl cells when
treated with sanguinarine concentrations of LS ~g/ml and 12.5 ",glm!. Each data point
represents the mean ± SE for three experiments carried out in duplicate. The graph shows
a 20 ±2.8% increase in 'ICT in cells undergoing peD and a 40 ± 3.5% (p value =0.004 vs
control) increase in cells undergoing BCD in K562 cells but not in 1M I cells
p value: 0.005
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~: Quantitative trypan blue exclusion in sanguinarine induced apoptosis (at 1.5
Ilglml) and BCD (at 12,5 Ilglml) ofK562 cells and of sanguinarine treated 1Ml cells
The graph shows all cell samples of both cell lines (control, PCD and BCD) excluding
trypan blue. Each data point represents the mean ± SE for three experiments carried out
intriplicale
SAllglmJ 0 1.5 1.5 12,6 12.5
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~: Quantitative propidium iodide exclusion in sanguinarine induc~ apoptosis
and BCD of K562 cells and of 1M I cells treated with sanguinarine. The graph shows all
cell samples of both cell lines (control, PCD and BCD) excluding PI. Each data point
represents the mean ± SE for three experiments carried out in triplicate.
"
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~ Cell surface membrane phosphatidyl serine (PS) flip as measured by the
annexin V assay in sanguinarine induced apoptosis (1.5 Ilglml) and blister cell death
(12.5 Ilglml) in KS62 cells and in JM] cells treated with sanguinarine. After staining the
cell samples with annexin V and FlrC, the number of annexin V positive cells were
quantitated by FACS analysis. Each data point represents the mean ± SE for three
experiments carried out in triplicate. 45 ± 6.1 % (p value =0 0.03 vs control) of KS62 cells
undergoing PCD was positive for annexin V binding while all other cell samples (BCD of
KS62 cells, 1Ml cells treated with sanguinarine and control untreated cells) did not show
the PS flip
j)
p value< O_O~
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12.6 12.6
~ Terminal deoxynucleotidyl transferase (TdT) end labeling assay was utilized
to detect damaged nuclear DNA in K562 and JM: 1 cells treated ""1th sanguinarine
(original magnification- ><200). Apoptotie 1<562 cells induced by sanguinarine showed
DNA nicking (5b), whereas, BCD of K562 cells (5e), 1Ml cells treated with either
concentration of sanguinarine (5e and Sf), and untreated control cells (Sa and 5d) failed 10
show nicking.
•
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~ A flow cytometric dot-plot, showing sanguinarine auto·fluorescence in
control (a), peD (b) and BCD (c) of K562 cells as well as control (d) and sanguinarine
treated 1M1 cells (e and f). While BCD of K562 cells (c) showed a higher level of
fluorescence than JMI cells treated with a similar concentration of sanguinarine (t), the
apoptosis of K562 cells (b) showed comparable levels of fluorescence to its 1M I
counterparts (e).
K562 12.5 (BCD +)
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Jm1 12.5 (BCD-)
Figure 2-7: Percentages of cells in the histogram of flow cytometric analysis showing the
expression of Bc1-2 In control (untreated) K562 (a) and 1Ml (b) cells. (a) Histogram of
Bcl-2 protein expression in untreated control K562 cells, The percentage of Bc1-2
positive cells is 33.88% and Bcl-2 negative cells is 66,77%. (b) Histogram of Bc1-2
protein expression in untreated control 1M I cells. The percentages of Bc1-2 positive cells
and Bcl-2 negative cells are 76.75% and 24.02%, respectively. Ml denotes the
percentage of cells negative for the protein while M2 denotes the percentage of positive
cells.
"
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Abstract
Sanguinarine, a benzophenanthridine alkaloid, has ami-cancer potential through induction
of cell death. Previously we have demonstrated that sanguinarine treatment at a low level
induced apoptosis or programmed cell death (PCD) in the Bcl-2 low-expressing K562
human erythroleukemia cells, and a high level induced blister cell death (BCD); whereas
Bcl-2 over·expressing sanguinarine-treated 1MI pre.B lymphoblastic cells displayed
neither apoptosis nor BCD morphologies. Here, we report that sanguinarine-treated K562
cells, when analysed by western blot, showed significant increase in expression of the
pro-apoptotic Bax protein in apoptosis, but not in BCD. eDNA expression array of PCD
in K562 cells failed to reveal the presence of Bax at the gene transcript level, which
suggests that this cell death process does not require de /lOVO protein synthesis. Treated
1M I cells, on the other hand, showed an increase in the expression of Bcl·2 protein in
both forms of cell death, but failed to show Sax expression. The role of other members of
the Bcl·2 family remained negligible, Caspase-3 activation was observed in apoptosis of
K562 cells but not in BCD or in sanguinarine-treated WI cells. These results suggest
that sanguinarine in K562 cells induces apoptosis through increasing Sax and activating
caspase·3, whereas sanguinarine-induced BCD involves neither, These results also
suggest that in WI cells, Bcl-2 may be associated with susceptibility of cells to induction
of apoptosis and BCD.
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Introduction
Sanguinarine is a benzophenanthridine alkaloid derived from the plant,
Sanguinaria canadensis, of the Papaveraceae family (Shamma and Guinaudeau, 1986)
Its principle medicinal use to date is in dental products based on its antibacterial,
antifungal, and anti-inflammatory activities, which reduce both gingival inflammation
and supragingival plaque formation (Kuftinec et al., 1990; Laster and Lobene, 1990;
Godowski et al., 1995). Sanguinarine has also been reponed to have antiviral and,
moreover, antitumor activity (Colombo and Bosisio, 1996; Faddeeva and Beliaeva, 1997;
Ahmad et a/., 2000).
Biochemical studies indicate that sanguinarine has multiple cellular targets (for
review, see Walterova et a/., 1995). For example, it can interact with and intercalate
DNA (Nandi and Maiti, 1985), inhibit microtubule assembly (Wolff and Knipling, 1993),
and inhibit a wide variety of enzymes, including Na+/K+ ATPase (Scifen et al., 1979)
Most interestingly, it is also a potent inhibitor of protein kinases (Wang et at., 1997) and
NF·K8 (Chaturvedi et ar, 1997), which are involved in signal transduction pathways
leading to cell proliferation and/or programmed cell death (PCD or apoptosis). Apoptosis
is a process of active cell death characterized by cell surface blebbing, changes in
membrane permeability and nuclear DNA condensation and internucleosomal
fragmentation (Liepins, 1989; tiepins and Bustamante, 1994). The latter event is
considered to be a hallmark ofapoptosis (Arends et al., 1990; Compton, 1992)
Our previous studies have demonstrated that K562 human erythroleukemia cells,
when exposed to the alkaloid sanguinarine at concentrations of 1.5 Ilg/ml and 12.5 Ilg/ml
for two hours, displayed the morphologies of two different modalities of cell death: at 1,5
6l
!1g/ml tbe classical morphology of apoptosis or programmed cell death (PCD) and at
concentrations of 12.5 Ilg/ml, the morphology of single blister formation or blister cell
death (BCD) (Weerasinghe et aI., in press). Previous observations in our laboratory of
apoptosis or programmed cell death (PCD) and blister cell death (BCD) induced by the
semisynthetic benzophenanthridine alkaloid derivative Ukrain™ in K562 cells was
termed "bimodal cell death" (BMCD) (Liepins et al., 1996). Thus, this dual cell death
modality induced by sanguinarine was also termed ''bimodal cell death" (BMCD).
Bcl-2 is known to be the prototype member ofa family of genes that positively or
negatively regulate apoptosis (Reed, 1998). Bcl-2 was also shown to be expressed in a
variety of tissues and to inhibit the induction of apoptosis in many experimental systems
(McDonnel el al., 1996). The product of the Bax gene, another member of the Bcl-2
family that forms heterodimers, has been shown to induce the apoptotic cell death process
(Yin et aI., 1994), Increased Bax expression may overcome Bcl·2-mediated cell death
suppression following a death-inducing stimulus (Oltvai et al., 1993). It has also been
suggested that the relative amounts of Bcl-2 and Bax may determine the susceptibility of
a cell to apoptosis (Korsmeyer et al., 1993)
Apoptosis has been postulated to occur via execution by a family of cysteine
proteases called caspases (Nunez et aI., 1998). These death proteases are pan of a
proteolytic caspase cascade that is activated by diverse apoptotic stimuli from outside and
inside of the cell. Enzymatic activation of initiator caspases, such as caspase-3, leads to
proteolytic activation of downstream effector caspases and cleavage of a number of vital
proteins, resulting in physiological, noninflammalory death and removal of apoplotic
bodies by neighboring cells (Nunez et aI., 1998; Salvesen, 1999)
This report indicates that sanguinarine.induced apoptosis in Bc!·2 low-expressing
K562 erythroleukemia cells (Kobayashi et aI., 1998) involves Sax protein induction and
caspase-3 activation, and that sanguinarine.induced BCD did not trigger caspase-3
activation and was Sax independent. In contrast, in Bcl-2 over-expressing 1M! pre-B
lymphoblastic cells (Samson et aI., 1996), sanguinarine was unable to trigger caspase-3
activation or Sax induction. However, 1M1 cells treated with sanguinarine showed an
increase in the expresssion of Bcl·2.
Materials and Metbods
MaUrials
The K562 human erythroleukemia cell line as well as the &1·2 over-expressing
1MI human B cell leukemia cell line were obtained from American Type Culture
Collection (Rockville, MD, USA). These cells were cuhured in RP.Ml 1640 medium
supplemented with L. glutamine and 111'10 fetal calf serum. They were maintained in a
37"0 5% C~, fully humidified incubator and passaged 4·5 times weekly.
The drug sanguinarine was purchased from Sigma Chemicals (St. Louis, MO,
USA) and maintained as a dry powder at room temperature. It was dissolved in
deionized water at Img/ml, and used as a stock solution. Sanguinarine was subsequently
diluted with RPMl 1640 in order to make a working solution of 50 I1gfml and serial
dilutions thereof
The ATLAS eDNA expression array was from Clontech Laboratories (palo AJto,
CA, USA) Jl;p dATP (6.00 Cilmmol) was purchased from DuPont New Research
ProduClS (Boston, 1I.iA,. USA). Caspase 3 assay kit was from Becton Dickinson Co. (San
Diego, CA, USA)
Cell culture
Cells were grown in RPM! 1640 culture medium supplemented with II1'Ie fetal
calf serum (Gibco BRL, Gaithersburg, MD, USA) in 75 ml culture flasks to densities
approximately 106 cells/ml.
Drug treatment
The following experimental format was used in order to prepare the cells for
subsequent experiments. Logarithmically growing K562 and JMI cells were placed in
..
6O-mm dishes at approximately 3x106 cell simI. Thereafter, serially diluted sanguinarine
concentrations of 0, 19,039,0.78, 1.56,3.\2,6.25, \2.5 and 25 Jlgfml were added to the
petri dishes and incubated for 2 hrs in a 37'CI5% CD,; incubator. Thereafter, cells that
underwent PCD and BCD (at concentrations of 1.5 Jlgfml and 12.5 Jlgfml respectively)
were used for morphological analysis, caspase-3 assay and protein isolation from cells
Quantitative morphology
The percentage of cell death, (i.e. apoptosis and blister cell death) corresponding
to each drug concentration was deterntined by light microscopy. The key morphological
criterion for apoptosis was the formation of apoptotic bodies and the key criterion for
blister cell death was the formation of cell surface blisters. Number of apoptotic cells and
blistering cells were counted using a hemocytometer.
Caspase-3 assay
Caspase·3 (CPP.32) activity was detennined by measuring proteolytic cleavage
of the specific fluorogenic substrate N-acetyl-Asp-Glu-Val-Asp-7-amino-4-
tritluoromethyl coumarin (Ac-DEVD-AFC), based on the peptide sequence of caspase-3
cleavage site of poly (ADP-ribose) polymersase (Evdokiou, 1999). Specific caspase-3
inhibitor N-acetyl.Asp·Glu-Val-Asp-CHO (Ac-DEVD-CHO) was used as a negative
control. Cells were cultured for 2 hrs in the presence of sanguinarine 1.5 jlgfml and 12.5
Jlg/ml with untreated cells as controls, washed in Phosphate Buffered Saline (PBS), and
resuspended in NP-40 lysis buffer
The cell lysate was added to each tube containing 8 JlM of substrate in I ml of
protease buffer {50 roM HEPES, 1(Jl1o sucrose, 10 nu\1 dithiothreitol and 0.1% 3
[(chloramido propyl) dimethyl amino] -\- propanesulphonate, pH 7.4} in the presence
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and absence of the inhibitor Ac-DEVD-CHO, and the mixture was incubated at room
temperature for 45 min. Caspase-3 activity was quantitated by measurement of yellow
green fluorescence at 505 nm (excitation at 400 nm) due to release of AFC in ALS50
spectrofluorimeter (perkin Elmer Co., Norwalk, CT)
PAGE-SDS and Western blotting
The effect of sanguinarine on expression of apoptosis-associated proteins
including BcI-2, Bax, Bak, Bad, Bik/Nbk, BcI-Xs, Bid, BcI-XL, p53, and CPP-32, were
detennined by western blotting analysis using previously described methods (pixton,
1990; Towbin et al., 1979) with minor modifications. Briefly, 107 cells were pelleted,
washed twice in Phosphate Buffered Saline (PBS), resuspended in 50 III PBS and lysed in
lysis buffer. The lysate protein was quantified using a DC protein assay kit (Amersham,
Piscataway, NJ) and 20 Ilg protein/lane were boiled 5 min, resolved by 12% sodium
dodecyl sulfate-polyacrylamide gel electrophoresis and electrobloned to nitrocellulose
The blots were blocked with PBS, 0,05% Tween 20 and 5% non-fat dried milk for I hat
22°e, incubated in blocking solution containing primary antibody (Santa Cruz
Biotechnology, Inc., Santa Cruz, CA), washed thrice for 5 min in TBS-T and then
incubated with I :2500 dilution of horseradish peroxidase conjugated secondary antibody
(Santa Cruz) for I h at 22°e. Blots were again washed thrice for 5 min in TBS·T and
then developed by chemiluminescence (Amersham, Arlington Heights, IL).
RNA isolation
TOlal RNA was prepared according to Chomczynski and Sacchi and used for the
ATLAS cDNA expression array (Chomczynski and Sacchi, 1987).
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Briefly, cultured K562 cells (5xlO' cells) and cells treated with sanguinarine \.56
jlgfml for 2 hours were washed twice in PBS and immediately homogenized in 3 ml of
ice cold Trizol (Life Technologies Inc., MO). After the addition of 600 jlg ofchloroform
(Life Technologies Inc., MD) and a IS minute centrifugation (lO,OOOxg, 40q, RNA was
ethanol-precipitated from the aqueous phase. Total RNA was resuspended in Rnase-free
water and the concentration assessed by absorbency at 260 nm using an UV spectro-
photometer
eDNA array hybridization
Gene expression was analyzed using the ATLAS cDNA expression array (Vegh
et aI., 1999) (a technique whose basic principle can be viewed as reverse Nonhem
blotting), in untreated control and apoptotic cells of K562 cells. The apoptosis cDNA
expression array consisted of 215 known apoptosis related genes belonging to eight
functional groups: I) cell cycle genes 2) P53 pathway genes 3) Bcl·2 family genes 4)
Caspases 5) Caspase regulators 6) ligand and receptors 7) other regulators of apoptosis 8)
house keeping genes. A mixture containing I Ilg of sample total RNA and 1 ,.d of lOx
CDS primer (Clontech) was incubated for 2 min at 70°C. Afterwards, an 8 III volume
containing I III of lOx dNTP, 0,5 III of dithiotreitol (100 mM), 3.5111 of e2P]adATP
(lOmCilml), till of25 mM Mgcb, 1111 of lOx PCR buffer (Clontech) and IIII ofMMLV
reverse transcriptase was added, and the solution was mixed and incubated for 25 min at
50°C. The reaction was terminated with the addition of I III of lOx termination mix at
room temperature. The reverse transcribed sample was applied to the center of the gel
bed in a Chroma Spin-200 column (Clontech) and allowed to fully absorb into the resin.
Successive column washes of 40 III and 250 III of diethylpyrocarbonate treated water
were followed by four successive fractionations using 100 III of diethylpyrocarbonate
treated water. The second and third fractions were pooled, mixed with 22 III of lOx
denaturing solution and incubated at 6SoC for 20 min, Next, 5 III of human Cot· I DNA (I
1lg/J.1I, Clontech) and 225 J.11 of 2x neutralizing solution were added and the labeled
cDNA was then added to 5 ml of ExpressHyb hybridization solution (Clontech) with 150
Ilg/ml sheared salmon testis DNA (Sigma, St. Louis, MO, USA) to reach a final probe
concentration of IxI06 c,p.m.lml and freshly applied to the ATLAS cDNA expression
array membrane, which was prehybridized in 10 ml ofExpressHyb hybridization solution
at 68°C in a roller bottle overnight. The membrane contains eDNA fragments
representing 250 human apoptosis related genes. Eaeh eDNA fragment is 200-500 bp
long and is selected as a unique sequence without poly (A) tail, repetitive elements, or
highly homologous sequences to minimize cross-hybridization and nonspecific binding
of cDNA probes. The amount of each cDNA fragment on the membrane is lOng, and
each cDNA fragment is immobilized in duplicate. Hybridization proceeded overnight at
68°e in a roller bottle. Membranes were stringently washed with agitation for 20 min in
200 ml of pre warmed (68°C) solution I (2x standard saline citrate, 1% sodium dodecyl
sulfate) four times and solution 2 (O.lx standard saline citrate, 0.5% sodium dodecyl
sulfate) twice. Afterwards, membranes were rinsed in O.Ix sse and exposed to X-ray
film for 3-7 days at-80°C.
Statistical analysis
The results are presented as means ± SE Statistical analyses were performed
using the student's t test. Differences were considered significant when p< 0.05.
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Results
Sanguinarine-induced cell death
The effect of sanguinarine on cell death was examined in Bcl-2-overexpressing
and low-expressing cells. Cell surface blebbing and shedding of apoptotic bodies (PCD)
and blister fonnation (BCD) was examined by light microsoopy and quantitated (Fig.3-
1). Over 96% of 1.5 j.Ig1ml sanguinarine-treated low Bel-2 expressing K562 cells
displayed apoptosis morphology (Fig.3-2a), whereas 12.5 j.Ig1ml induced more Ihan 900;..
BCD (Fig.3-2b). Using the same conditions, high Bel-2 expressing JMl cells displayed
no apoptosis, and showed BCD in fewer than 10010 of cells (Fig.3-l)
Effect of sanguinarine on expression of apoptosis-associated proteins
To study expression of apoptosis-regulating proteins of the Bcl-2 family and p53
during sanguinarine-induced apoptosis at 1.5 j.Ig1m1 and BCD al 12.5 j.lglml, Western blot
analysis was used on K562 and 1M! cell extracts. Compared 10 untreated control K562
cells, the expression of pro-apoptotic Bax prolein was found to be increased in
sanguinarine·induced apoptosis (FigJ-3). In contrast, sanguinarine-induced BCD was nOI
accompanied by any significant increase in Bax protein expression. Treatment of JMI
cells with conditions that induce apoptosis and BCD in K562 cells failed to induce any
significant change in Bax expression (FigJ-3). In K562 cells, no change was observed in
the low expression of the Bel-2 protein in apoptosis and BCD. In contrast, 1Ml cells
showed an increase in Bel-2 in low and high sanguinarine concentrations (Fig.3-4)
However, the expression of pro-apoptotic Bak, Bad, Bik/Nbk, Bel-Xs, Bid, and p53 and
anti-apoptotic Bel-XL proteins was not significantly effected by sanguinarine in either
cell line at low level or high level (individual data not shown).
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K562 and IMl cells contained high endogenous levels of the 32 kDa procaspase-3
(Fig.3-5). However, the 20 kDa activated caspase-3 product was only observed in
apoptosis ofK562 cells. Fluorimetric analysis results confirmed the activation ofcaspase-
3 observed by Western blot analysis (FigJ-6). Caspase·3 activation was seen in only
K562 cells in the apoptosis-inducing concentration
Results of cDNA expression array of PCD in K562 cells
This study enabled the simultaneous examination and analysis of changes at multiple
gene transcript levels in sanguinarine induced apoptosis, as compared to untreated control
K562 cells. The purpose of this study was to detect any changes in Sax expression or that
of any other member of the Bcl·2 family of proteins at the gene transcript level. We
observed no Bax gene (or any other member of the Sc1·2 family) expression in PCD at
the mRNA level.
72
Discussion
K562 human erythroleukemia cells when treated with sanguinarine increase
expression of the prcrapoptotic Bax protein during PCO while showing the
morphological characteristics of apoptosis. In contrast, the Bcl-2-overexpressing lMl
cells when subjected to sanguinarine treatment showed an increase in the anti-apoptotic
Bel-2 expression with no changes in Sax expression and failed to show the
morphological characteristics of apoptosis when treated with concentrations that induced
apoptosis in K562 cells (1.5 Ilglml). These results suggest that the Bel-2IBax ratio may
determine the susceptibility of cells to apoptosis during sanguinarine treatment The
proto-oncogenes Bcl-2 and Bax are known to inhibit and accelerate apoptosis,
respectively (Reed et aI., 1994; Krajewski el ai., 1995). In addition, the ratio of the Bcl-2
and Bax proteins was found to correlate with the chemotherapeutic effect (Nakata et aI.,
1998). It has also been observed that tumor cell apoptosis following chemotherapy is
essential for chemotherapeutic efficacy (Barry el al., 1990; Nakata el aI., 1998)
Consistent with these studies, our findings indicate that the BaxlBel-2 ratio in cells could
be a detennining factor in the induction of apoptosis by sanguinarine. Another notable
observation in the present study was that sanguinarine induced bimodal cell death
(BMCO) in a p53 independent manner.
Considerable research has been devoted to study the activation of the protease
cascade in drug-induced and other forms ofapoptosis, as well as the ability of Bcl-2 and
Bcl·2-related proteins to inhibit this process (Wang el al., 1997; Irabo el aI., 1996)
Sanguinarine treatment of Bcl-2 low-expressing K562 cells resulted in the
activation/cleavage of caspase- 3 into 20 kDa breakdown products. The Bcl-2·
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overexpressing JMI cells, on the contrary, showed no breakdown products ofcaspase· 3
Therefore, these results show that, elevated Bc1-2 may be associated with failure to
trigger caspase 3 activation, which is in agreement with several recent reports (Kojima et
ar, 1996; lrabo et aJ., 1996). These results also appear to be in agreement with recent
literature, which suggests that in the case of some, but perhaps not all cytotoxic stimuli,
BcI-2 functions upstream of a critical cysteine protease involved in the degradation phase
ofapoptosis (Wang et al., 1997). As opposed to the function of Bc1-2. increased levels of
Bax promote caspase 3 activity in sanguinarine-induced apoptosis. In contrast, the
absence of caspase 3 activation during BCD may indicate that this may not be a
necessary element in the execution of BCD.
Compared to the abundance of literature penaining to apoptosis. the phenomenon
ofBCD is, at best, only sporadically reponed. This morphological phenomenon of blister
fonnation may resemble "blebbing" as previously described by Majno and loris (1995)
and Phelps el al. (1989). Trump et aJ. (1997) and Trump and Berezesky (1992) associates
blebbing with increases in concentration of cytosolic calcium and rearrangement of
cytoskeletalproteins.
Our results show that low Bcl-2 expressing K562 cells treated with sanguinarine
12.5 Jlglml, underwent BCD without significant changes in the expression of Bc1-2 and
Bax. Furthermore, the elevated BcI·2 expressing 1Ml cells when exposed to a similar
concentration of the drug failed to undergo the morphology of BCD and at the same time
showed an increase in Bc1·2 with no change in Bax expression. Thus, it appears that cell
susceptibility to BCD may be associated with Bc1-2 levels, as opposed to the BaxlBcl-2
ratio in PCD. The increase ofBc1-2 during sanguinarine treatment of JMI cells (which
may have prevented these cells from undergoing PCD and BCD) may have been brought
about by a mechanism downstream of the initiation of the toxicity by the drug. Recent
literature has also shown evidence of inhibition of cyplasmic blebbing by Bc1-2 (Ferri et
al., 2000), This increased expression of Bc1-2 may change the expression of drug targets
or drug transport across the plasma membrane or it may change the capacity of the cell to
repair damage induced by the drug. More imponantly, this may indicate that the
overexpression of the Bcl-2 gene is another factor contributing to drug resistance by
assuming a dual role ofanti-PCD and anti-BCD.
Studies of sanguinarine-induced PCD in K562 cells using cDNA expression
analysis showed, contrary to expectations, the lack of Bax at the gene transcript leveL
This indicates that the increase in cellular protein expression in sanguinarine-induced
bimodal cell death may have been the result of post-translational modification of proteins
rather than its synthesis de novo, This notion was funher strengthened by our studies,
which showed the failure of the protein synthesis inhibitor cycloheximide to inhibit peD,
and BCD in K562 cells (data not shown). This illustrates the importance of the
endogenous Bcl-2 levels in 1Ml cells, in determining the resistance of these cells to
sanguinarine induced peD and BCD. In contrast, as aforementioned, the low Bcl-2
expressing K562 cells, despite being considered a drug resistant cell line (Kobayashi et
aI., 1998) underwent peD and BCD with relative ease, when induced by sanguinarine.
The resistance of 1MI cells to peD and BCD mediated by endogenous Bcl-2 during
sanguinarine treatment, albeit via different pathways, may help understand the
mechanism ofchemoresistance, at least for sanguinarine.
"
Apoptosis is not the sole cell death mechanism (Houghton, 1999). Thus, the need
to explore new forms of cell death mechanisms remains. Our findings demonstrate that,
at least in the case of sanguinarine. tumor cell death may also be induced by BCD, a
hitheno less understood form of cell death. We believe that the discovery of novel anti-
cancer agents and their individual patterns and mechanisms of cell death may have an
imponant bearing in overcoming chemoresistance.
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~ Quantitative morphological analysis of K562 and IM1 cells. K562 cells
treated with sanguinarine 1.5 Ilglm1 show the morphology of apoptosis in about 96% of
cells (. p value = 0.0003 versus control), and when treated with concentrations of 12.5
Ilglml, the morphology of BCD (single blister formation) in over 90% of cells (. p value
= 0.0004 versus control). However, 1M! cells treated with the same concentrations of
sanguinarine failed to show apoptosis, and BCD was shown in about 10% of cells.
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EiBJill.....1:2: Electron micrographs (original magnification- xI50(0) of sanguinarine
induced PCD and BCD ofK562 cells. The figure shows (a) apoptosis and (b) blister cell
death in K562 cells induced by treatment with sanguinarine 1.5 Ilg/ml and 12.5 Ilgfml
respectively for 2 hours. Fig. (a) show apoptotic bodies, nuclear fragmentation and
chromatin condensation, while fig. (b) show blister formation, patchy chromatin
condensation and an increase in vacuolization
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~Western blot for Bax protein expression in K562 cells (lanes 1,2,3) and lMl
cells (lanes 4, 5, 6)[untreated (lanes 1 & 4) or treated with sanguinarine 1.5 Ilglml (lanes
2 & 5) or 12.5 Jlg/ml (lanes 3 & 6)], using a total cell extract of 50 Jlg per lane. Lane 7
shows positive control for Bax antibody. Results show an increased thickness in the Bax
band in PCD ofK562 cells
81
SApglml
1234567
o 1.5 12.5 0 1.5 12.5 -
K562 K562 K562 JM1 JM1 JM1 +cont
PCD+ BCD+ PCD- BCD-
82
Figure 3-4- Western blot for Bc1·2 protein expression in K562 cells (lanes I, 2, 3) and
JMl cells (lanes 4, 5,6) [untreated (lanes I & 4) or treated with sanguinarine 1.5 Ilg/ml
(lanes 2 & 5) or 12.51lg/ml (lanes 3 & 6)], using a total cell extract of20 Ilg per lane.
Lane 7 shows positive control for Bc1·2 antibody. 1MI cells treated with sanguinarine
showed an increase in Bc1-2 expression. The levels of Bc1-2 in treated and untreated
K562 cells were relatively insignificant.
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~ Western blot for Caspase·3 in K562 cells (lanes 2, 3, 4) and 1Ml cells (lanes
5, 6, 7) [untreated (lanes 2 & 5) or treated with sanguinarine LS ~g/ml (lanes 3 & 6) or
12.5 ~glml (lanes 4 & 7)], using a total cell extract of 20 ~g per lane. Lane 1 shows
positive control for Caspase·3 antibody_ Results show only pcn of K562 cells with 20
kDa breakdown products of caspase-3 and hence its activation
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pco- BCD·
~: Caspase-3 activation assay in KS62 and JMl cells treated with sanguinarine
Fluorimetric analysis of caspase-J activation was positive during apoptosis of KS62 cells
(* p value = 0.003 versus control) but negative during BCD. Thil cells treated with 1.5
)1g1ml and 12.5 )1g1ml of sanguinarine did not show caspase-3 activation. Caspase-3
activation in sanguinarine induced apoPlosis in K562 cells was diminished upon
treatment with the caspase-3 inhibitor (DEVD-CHO). Results represent the mean ± SE
from 3 independent experiments
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Abstract
The apoptOsis related proteins: Bax, Bc1·2 and NF-xB were analyzed in
sanguinarine induced apoptosis and blister cell death (BCD) of K562 erythroleukemia
cells, and in sanguinarine treated high BcI-2 expressing 1MI pre--B lymphoblastic cells,
utilizing immunofluorescence-flow cytometry. Sanguinarine induced apoptosis of KS62
cells was found to have increased Bax expression and de<:reased NF·xB, whereas BCD
showed a decrease in Bax expression and an increase in NF-xB. In contrast, high BcI-2
expressing 1M I cells when exposed 10 the same concentrations (and duration) of
sanguinarine that induced PCD and BCD in K562 cells, failed to show the respective
molllhologies while showing a concomitant increase in Bc1·2. Results from studies with
KS62 cells suggest that Bax is pro-apoptotic, and also that an increase in JI.'F-xB may be
associated with BCD. Results from studies with 1MI cells suggest Ihat Bd-2 is anti-
apoptolic and ami-BCD. Results from 1Ml cells strengthen the assumption in literature of
the central role BcI·2 plays in chemoresislance by assuming an anti·PCD role. These
results also suggest lhat in 1Ml cells, Bcl-2 may funher complicate chemoresistance by
being ami-BCD in nature, in addition to its anti·PCD role.
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Introduction
Our previous studies have demonstrated that K562 human erythroleukemia cells,
when exposed to the alkaloid sanguinarine at concentrations of 1.5 Ilglml and 12.5 Ilglml
for two hours, displayed the morphologies of two different modalities of cell death: at 1.5
Ilglml the classical morphology of apoptosis or programmed cell death (PCO) and at
concentrations of 12.5 Ilglml, the morphology of single blister formation or blister eel!
death (BCD) (Weerasinghe et 01., in press). Previous observations in our laboratory of
apoplosis or programmed cell dealh (PCO) and blister cell death (BCD) induced by the
semisynthetic benzophenanthridine alkaloid derivative Ukrain™ in K562 cells was
termed "bimodal cell death" (BMCO) (Liepins ef aI., 1996). Thus, this dual cell death
modality induced by sanguinarine was also termed "bimodal cell death" (BMCO).
Furthermore, these two morphologically distinct modalities of cell death were
interphased by a period of apparently normal cell morphology (silent period) based on
light microscopy and a relatively lower degree of$lCr release than that during blister cell
death (BCD) (Liepins et 01., 1996).
Sanguinarine (13-methyl [1,3]benzodioxolo[5,6-C]-1 ,3-dioxolo[4,5-
i]phenanthridinium) is derived from the root of Sanguinaria caJladensis and other poppy-
fumaria species (Chaturvedi et aI., 1997; Bajaj et aI., 1990). It belongs 10 the
benzophenanthridine family of alkaloids and has a wide range of potentially useful
medicinal properties, such as antifungal, antiprotozoal, antibacterial and antiviral
activities (Walterova et aI., 1995). Sanguinarine is also a known PKC (protein kinase C)
inhibitor (Gopalakrishna et aI., 1990), a DNA intercalalor (binding to guanosine-cytosine
rich regions) (Babich et aI., 1996; Sen and Maiti, 1994), a putative topoisomerase I and II
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inhibitor (Hsiang ef aJ., 1989; Zhang ef aJ., 1990), an inhibitor of tubulin assembly
(Wolff and Knipling, 1993) and an inhibitor of Na+/K+ ATPase (Seifen ef aI., 1979;
Straub and Carver, 1975)
Programmed cell death (PCD), or apoptosis, is a physiological cell death process
characterized by the formation of apoptotic bodies, changes in membrane permeability,
elevated oxygen consumption rates and nuclear DNA condensation with or without
fragmentation (Liepins, 1989; Liepins eJ aJ., 1996). The latter event, Le.,
internucleosomal DNA fragmentation, may not occur in some experimental systems
(Stewart, 1994; Liepins and Bustamante, 1994), although considered to be the hallmark
of apoptosis (Arends et aJ., 1990; Compton, 1992). Sanguinarine induced apoptosis did
not show DNA laddering (intemucleosomal DNA fragmentation) in gel electrophoresis
(Liepins et aI., 1996). However, DNA nicking was demonstrated in these cells by the
terminal deoxynucleotidyl transferase (TdT) end labeling method (Weerasinghe et aJ., in
preparation)
Membrane permeability studies with K562 cells have shown that both PCD and
BCD are associated with increases in 5l Cr release. However, the cytoplasmic membrane
of both PCD and BCD was found to exclude trypan blue, denoting viability (Weerasinghe
et aI., in preparation). The phosphatidyl serine (PS) flip associated with apoptosis,
assessed by the annexin V assay, was positive in PCD but negative in BCD (Weerasinghe
etal., in preparation)
BcI·2 was found 10 be activated in the majority of follicular non-Hodgkins's
lymphomas (Reed eJ al., 1994). Initially, the function of Bcl-2 was viewed, like many
other oncogenes, as promoting proliferation. Recently, it has been shown to function as
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an inhibitor of apoptosis (Korsmeyer, 1999). The product of the Bax gene, another
member of the Bcl-2 family that forms heterodimers, was also found to be involved in the
apoptotic cell death process (Yin el aI., 1994). Increased Bax expression may overcome
Bcl-2 mediated cell death suppression and result in accelerated apoptotic cell death
following a death-inducing stimulus (Oltvai et a/., 1993). It has also been proposed that
the relative amounts of Bcl-2 and Bax may he considered as a ''rheostat'' which
detennines the susceptibility of a cell to undergo apoptosis (Korsmeyer el al., 1993)
The transcription factor NF-lCB has been recognized as an anti-apoptotic regulator
(Kajino el a/., 2000). However, the mechanism by which r..lf-KB blocks apoptosis is still
controversial (Kajino et at., 2000). NF-KB encompasses a family of inducible
transcription factors that play a critical role in the regulation of gene expression in
response to various environmental challenges, including inflammatory stimuli, infectious
agents and oxidative stress (Baeuerle. 1998). It is also suggested that de novo protein
synthesis is dispensable for anti-apoptotic effects of NF-KB and support the possibility
that NF·K8 could exert its anti-apoptotic action through protein-protein interaction
(Kajino et 01.• 2000)
A multitude of methods has been described to identify apoptotic cells by flow
cylometric analysis (Darzynkiewicz el a1.. 1997), The present study is aimed at
understanding the inter-relationship between Bax, Bcl-2 and NF-lCB in the twin cell death
modalities of programmed cell death (PCD) and blister cell death (BCD) induced by
sanguinarine in the low Bcl-2 expressing K562 cells, and comparing these results vis-a-
vis those obtained in similar experiments in the high Bcl-2 expressing 1M1 cells. treated
with the same concentrations (and duration) of sanguinarine that induce PCD and BCD in
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K562 cells, utilizing immunofluorescence-flow cytometry. The JMl human pre.S cell
lymphoblastic cell line constitUlively expresses elevated endogenous levels of the Bcl-2
gene product (Samson el a/., 1996), while the K562 human erythroleukemia cells express
low levels (Kobayashi et oJ., 1998) (these findings are also confirmed in the present
study).
..
Materials and Methods
Material!
The K562 erythroleukemia cell line as well as the 1MI human B cell leukemia
cell line were obtained from ATCC (Rockville. MO), RPMl 1640. L.g1utamine and fetal
calf serum were from omco BRL (Gaithersburg. MO). Sanguinarine was purchased
from Sigma Chemicals (St. Louis. MO) and maintained as a dry powder at RT.
Sanguinarine was dissolved in deionized water and used as a stock solution of I rng/ml
Primary antibodies for Bc\·2 and Bax were purchased from Santa Cruz Biotechnology
(Santa Cruz. CAl. NF·KB antibody was kindly provided by Dr. Karen Mearow (Memorial
University of Newfoundland). Secondary antibodies conjugated to FITC were also
purchased from Santa Cruz Biotechnology.
Cell culture
Bcl·2 over expressing 1MI B cell lymphoma and K562 erythroleukemia cell lines
were cultured in RPM! 1640 medium supplemented with L-g1utamine and 10% fetal calf
serum (Omco. BRL). at3i'Cl8% CO2 in a humidified incubator.
Sanguinarine treatment
Sanguinarine HC) (Sigma Chemical Co.• St. Louis, MO) was dissolved in
distilled water at a concentration of 1.0 mg/m!. Serial dilutions were carried out (shonly
before in vitro use) with tissue culture medium [RPMl-I640 + 10010 fetal Bovine Serum
(FBS)]. The serial dilution of sanguinarine with RPMI-I640 + 10% FBS in 24 flat bottom
well plates yielded a concentration range of 25 )J.glml to 0.19 )J.glml (8 dilutions)
Triplicate wells of each drug concentration were prepared and aliquots of I x 106 cells
(K562 or JMI) per well were added. These tissue culture plates were subsequently
incubated at 3'f C + 5.0010 C{}z for two hours.
Light microscopy
Cells treated with sanguinarine were studied and quantitated by light
microscopy. The key morphological criterion for the detection of apoptosis was the
formation of apoptotic bodies and the key criterion for blister cell death was the
formation of cell surface blisters.
Electron microscopy
Cells were fixed with 2% glutaraldehyde, post fixed in 1% osmium tetroxide,
dehydrated through a series of ethanols and embedded in TAAB 812 epoxy resin. Semi
thin (0.5 ~m) sections were cut axially, through all layers of each pellet to select areas for
ultramicrotomy. Ultra thin sections were stained with lead citrate and 30% alchoholic
uranyl acetate and then examined in a JEOL lOO-Cx electron microscope
Flowcytometricanalysis
Flow cytometric analysis was carried out as described by Re et of. (1998). Briefly,
after treatment with appropriate concentrations of sanguinarine, K562 and JM I cells were
fixed with 70% ethanol for 20 minutes at 4°C. Cells were then washed twice with PBS
and permeabilized with 0.5% Triton X 100 (Sigma, St. Louis, MO) in PBS for 10
minutes at 4°C. After three washings with PBS, cells were resuspended in 10010 goat
serum for one hour at room temperature before adding anti-Bcl-2, Bax and NF-KB
monoclonal antibodies. (1:50, 1:90, 1:100, respectively) and incubated overnight at 4°C
The cells were then washed five times in PBS. Thereafter, a polyclonal goat anti-mouse
(1:100) or polyclonal goat anti-rabbit (NF-clJ 1:75) antibody conjugated to fluorescein
96
(FITC) was added to cells and incubated for 30 minutes at 3'fC. The cells were washed
five times and analyzed by FACS (Becton-Dickinson, Palo AJto, CAl.
Thereafter. the cells were gated for forward scatter (FSC) and side scatter (SSC)
in order to rule out cell aggregates and debris. The negative controls consisted of
identical secondary labeling without primary monoclonal antibody. The positive control
was Ihe expression of the HSP·70 housekeeping protein, which was detected by the anti
HSP-70 monoclonal antibody (I: 100).
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Results
K562 cells treated for 2 hrs with 1.5 ~glml of sanguinarine at 37"C displayed
formation of apoptotic bodies in over 96% of cells, whereas 1M I cells treated with a
similar concentration of sanguinarine did not display the morphology of apoptosis (Figs.
4-1b and 4-le respectively). K562 cells, treated with sanguinarine concentrations of 12.5
~glml displayed the morphology of single blister formation or blister cell death (BCD)
(Fig. 4.1c), whereas 1Ml cells failed to undergo this morphological phenomenon, when
treated with the same sanguinarine concentration (Fig. 4-1 f). Untreated control K562
cells and 1Ml cells are shown in Figs. 4-la and 4-ld respectively. Electron micrographs
of apoptotic K562 cells showed the classic morphological changes. consisting of
formation of apoptotic bodies (containing organelles), chromatin condensation and
nuclear fragmentation (fig. 4-2a). Electron micrographs of sanguinarine induced BCD in
K562 cells showed single blister formation (devoid of organelles), patchy chromatin
condensation and an increase in cytoplasmic vacuolization (fig. 4-2b).
Both cell lines were examined for changes in the pro-apoptotic Bax, anti-
apoptotic Bc1·2 and in the anti.apoptotic nuclear transcription factor NF->cB proteins,
subsequent to sanguinarine treatment utilizing immunofluorescence-flow cytometry. The
percentages of cells expressing the respective proteins were studied in PCD and BCD of
K562 cells, and also in sanguinarine treated 1MI cells, as compared to untreated controls
Results of flow cytometric studies of K562 cells in relation to the pro-apoptotic
Bax show an increase in the percentage of cells expressing high levels during PCD
(,,<81.79%) (fig. 4-3b) and a decrease during BCD ("<26.71%) (fig. 4-3c), compared with
untreated controls ("'43.50%) (fig. 4-3a). On the other hand, 1M1 cells treated with the
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same concentrations (and duration) of sanguinarine that induced PCD and BCD in K562
cells, did not show any significant change in Bax protein expression (figs. 4-3e and 4-3f),
when compared with untreated controls (fig. 4-3d).
When treated with sanguinarine, the percentage of K562 cells expressing Bcl-2
failed to show significant change during PCD (40.41%) (fig. 4.4b) and BCD (34.80%)
(fig. 4.4c) compared 10 control untreated cells (33.88%) (fig. 4-4a), In contrast, 1M1 cells
treated with sanguinarine (figs. 4-4e and 4-4f) showed an increase in the Bcl-2 content, as
compared to untreated controls (fig. 4.4d). Although failing to show any significant
change in the percentage of cells expressing BcI-2, the intensity of FITC fluorescence
was in fact significantly higher during sanguinarine treatment (given the logarithmic
scale by which FITC fluorescence is presented in the graph) (figs, 4-4e and 4-4f) as
compared to untreated controls (fig. 4-4d), This shift to the right is indicative of an
increased expression ofBcl·2
Results of NF-1<B expression in PCD and BCD of K562 cells showed an
interesting pattern. The percentage of K562 cells expressing NF-1<B during PCD showed
a significant decrease (17.38%) (4-5b), compared 10 untreated controls (42.23%)
However, during BCD of K562 cells induced by sanguinarine, 60.15% of cells contained
high levels ofNF-lC8 (4.5c), In comrasl, results of 1Ml cells treated with concentrations
of sanguinarine inducing PCD and BCD in K562 cells, show no significam change in the
percentage of cells expressing NF-KB (81.13% and 80.85%, respectively) (figs. 4-5e and
4-5f), when compared with untreated comrols (83.65%) (4-5d).
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Discussion
K562 cells exposed to sanguinarine at concentrations of 1.5 Ilglml for two hours
were found to increase the expression of Sax and decrease the expression of NF.KB,
while demonstrating characteristics of the classical morphology ofapoptosis. In contrast,
high Bc1-2 expressing 1M) cells, when exposed to a similar concentration and duration
(1.5 Ilglml for two hours) of sanguinarine, failed to show the morphology of apop1osis
Furthermore, these cells when treated with 1.5 Ilglml sanguinarine showed an increase in
BcI-2 expression, hut no significant change was detected in the levels ofBax and NF·.,£
These results suggest that sanguinarine induced apoptosis increases the expression of Sax
while decreasing NF-KB in K562 cells. On the other hand, high levels of endogenous BcI·
2 in 1M1 cells and its increased expression during sanguinarine treatment may have been
associated with preventing these cells from undergoing apoptosis
It has been reported that the proto-oncogene Bc1·2 inhibits apoptosis and confers
drug resistance to malignant cells while Bax accelerates apoptosis (Korsmeyer, 1999;
Reed et al., 1994; Krajewski et aI., 1995). The ratio of the Bcl-2 and Bax proteins was
found to correlate with the chemotherapeutic effect (Yang and Korsmeyer, 1996;
Krajewski et aI., 1995). These findings held true in PCD induced by sanguinarine. Our
results were also in agreement with the widely held notion of NF-KB being anti-PCD
(Kajino et al., 2000; Wang et aI., 1996); the high endogenous levels ofNF-KB in 1M1
cells might be associated with the resistance of these cells to PCD. It has also been
suggested that NF-KB can induce the expression of genes that contribute to proliferation
such as Bcl-2 (Mercurio and Manning, 1999). When treated with sanguinarine, 1M1 cells
expressing high levels of endogenous NF-KB, increased Bc1-2 expression Thus, it
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appean that the increase in the BaxIBcI-2 ratio on the one hand and reduction of NF-dJ
on the other, would represent a reasonable approach to cancer drug development., if the
uhimate goal was to create the necessary conditions for the facilitation of PCD in rumor
cells.
When 1<562 cells were exposed to sanguinarine concentrations of 12.5 }!Wml for
two hours, they displayed the morphology of blister fonnatio", which was previously
found to release 'ICr but exclude trypan blue (data not shown) (Liepins et or, 1996). The
exclusion of trypan blue and PI by BCD indicate that it is not representative of early
necrosis, as early necrotic cells lose plasma membrane integrity permitting the entry of
trypan blue into the cell (O'Brien et or, 1997)
Blister fonnation is at best, only sporadically reported in literature (Liepins et or,
1996; Phelps et a1., 1989). The phenomenon of BCD may resemble the "blebbing"
described by Majno and Joris (1995). Majno and Joris (1995) describe blebbing as blister
like, fluid filled structures, typically devoid of organelles, that arise from the cell
membrane and are apt to swell and burst. It is suggested that the mechanism of blebbing
may appear to depend on a disconnection between the cell membrane and the underlying
cytoskeleton (Majno and Joris, 1995; Phelps et oJ., 1989). Trump elof. (1997) and Trump
and Berezesky (1992) associate blebbing with increases in concentration of cytosolic
Ca1- [Ca-]i and rearrangement of cytoskeletal proteins including filamentous actin,
although Lemasters et al. (1987) saw no change in concentration of cytosolic Cal" rCa-]i
during blebbing. The rupture of these large cell surface blebs is thought to represent the
abrupt transition from reversible to irreversible cell injury (Lemasters el or, 1987).
101
When protein expression of BCD in response to sanguinarine Ireatment was
analyzed by immunofluorescence-flow cytomeuy we observed a decrease in Bax
expression and an increase in NF·1C8 levels. The decrease in Bax and increase in NF-JC8
during BCD in K.562 cells were diametrically opposite to that which was observed during
apoplosis. In contrast, !he high &1·2 expressing 1M I cells exposed 10 the concentration
and duration (12.5 f.Igfml for IWO hours) of sanguinarine that induced BCD in K562 cells,
failed to undergo the morphological changes of BCD. Protein expression analysis by flow
cytometry showed that changes in the expression of Bax and NF·JC8 were minimal.
However, the anti- apoptotic Bcl-2 protein showed an increase in expression during
sanguinarine treatment. These results suggests that while Ihe decrease in Bax and
increase in NF·KB may be associated with BCD induced by sanguinarine (as found in
K562 cells). on the other hand. high levels of Bcl-2 may be associated with protection
against sanguinarine induced BCD (as found in 1Ml cells).
Thus, from a pharmacological standpoint. !he correlalion between &1·2 and
chemoresistance was found to be convincing in !he Irealment of tumor cells with
sanguinarine. The role of high Bcl·2 expression and poor response to chemotherapy are
corroborated by recenl reports in literature (Yang and Korsmeyer, 1996). The findings of
the present study suggest that Ihe anti-apoptotic Bcl.2. apan from inhibiting the apoptotic
process might have also inhibited the process of BCD. Thus, Bcl·2 may also be anti-BCD
in addition to being anti·PCD. Evidence of Bcl·2 inhibiting the process of cytoplasmic
blebbing has also been reported in recent literature (Ferri et al., 20(0). Hence. the anti·
apoptotic Bcl-2 (as discussed earlier) may further compound chemoresistance by
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additionally being anti-BCD in nature (at least, this holds true in the case of sanguinarine
treatment).
It is stated that apoptosis is only rarely observed in vivo and may not be the sole
cell death mechanism (Houghton, 1999). Results of the present study show that
sanguinarine, apart from PCD, may induce tumour cell death by BCD-a hitheno less
understood form of cell death. The discovery of novel forms of cell death induced by
anti-cancer agents and identifying their mechanisms may have an important bearing in
overcoming chemoresistance
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~: Light micrographs (original magnification- x282) of K562 and lMl cells
treated with sanguinarine. Apoptosis (b) and blister cell death (c) in K562 cells treated
with sanguinarine at 1.5 lJg/ml and 12.5 lJg/ml respectively for 2 hrs. lMl cells, which
express high endogenous levels of Bcl·2, are resistant to the induction of apoptosis (e)
and blister cell death (f) at the corresponding sanguinarine concentrations Control
untreated K562 and 1Ml cells are shown in figs. (a) and (d) respectively.
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Figure 4-2: Electron micrographs (original magnification- xI5000) of sanguinarine
induced PCD and BCD ofK562 cells. The figure shows (a) apoptosis and (b) blister cell
death in K562 cells induced by treatment with sanguinarine 1.5 Jlg/ml and 12.5 Jlg/ml
respectively for 2 hours. Fig. (a) show apoptotic bodies, nuclear fragmentation and
chromatin condensation, while fig. (b) show blister formation, patchy chromatin
condensation and an increase in vacuolization.
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Figure 4-3: Flow cytometric analysis ofBax in K562 and 1Ml cells by histogram. (a) Bax
protein expression in untreated control K562 cells. The percentage ofBax positive cells is
43.5% and Sax negative cells are 56.99%. (b) Bax protein expression in sanguinarine
induced apoptotic K562 cells. The percentages ofBax positive cells are 81.79"/0 and Bax
negative cells is 18.79%. (c) Bax protein expression in K562 cells that underwent
sanguinarine induced BCD. The percentage of Sax positive cells is 26.71% and the
percentage of Bax negative cells is 73.85%. (d) Bax protein expression in untreated
control 1M] cells. The percentages of Bax positive cells and Bax negative cells are
26.64% and 74.02%, respectively. (e) Bax protein expression in JMI cells exposed to the
concentration and duration of sanguinarine that induce apoptosis in K562 cells (1.5
~g/ml). The percentage of Bax positive cells and Sax negative cells are 39.11% and
61.63%, respectively. (f) Sax protein expression in 1M! cells exposed to the
concentration and duration of sanguinarine that induced BCD in K562 cells (l2.5l-lg/ml).
The percentages of Sax positive cells and Bax negative cells are 37.48% and 63.89%,
respectively
10'
Q b c
.~ .~ 'lj~ ~ ~.. .. j; .~~ "' !~ "'."
='0 '0 ~Kl3 10'10° 10' ~ 10J 10~ 0'00 10' ~lC 103 10'
Ml~~_m;, Ml·~)5·~ "llwI87~. M2-8I.m. MI-73IS·.' M2~11i,71~;,
d e
.~ i!~ '~! !j: Ml ..!~ "'~'00 10' Jfi.c 103 10' ='00 10 ~C '0 10"100101~1O310'
:\-11-74,02% M2·26_6.~" 1\11"61.63°" '-U-39.11 ~. MI-6319'!" Ml-3HI!.
109
Figure 4·4: Flow cytometric analysis of Bc1·2 in K562 and JMI cells by histogram. (a)
Bc1·2 protein expression in untreated control K562 cells. The percentage of Bcl-2
positive cells is 33.88% and Bc1-2 negative cells is 66.77%. (b) Bc1·2 protein expression
in sanguinarine induced apoptotic K562 cells. The percentage of Bcl-2 positive cells is
40.41% and Bc1-2 negative cells is 60.05%. (c) Bc1-2 protein expression in K562 cells
that underwent sanguinarine induced BCD. The percentage of Bcl-2 positive cells is
33.80% and the percentage of Bcl-2 negative cells is 66.33%. (d) Bcl-2 protein
expression in untreated control JMI cells. The percentages of Bcl-2 positive cells and
Bcl-2 negative cells are 77.46% and 22.95%, respectively. (e) Bcl-2 protein expression in
1Ml cells exposed to the concentration and duration of sanguinarine that induce apoptosis
in K562 cells (1.5 )J.glml). The percentages of Bcl-2 positive cells and Bcl-2 negative
cells are 82.06% and 18.03%, respectively. (f) Bcl-2 protein expression in 1Ml cells
exposed to the concentration and duration of sanguinarine that induce BCD in K562 cells
(12.5 )J.glml). The percentages ofBcI-2 positive cells and Bcl·2 negative cells are 76.75%
and 24.02%, respectively.
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Figure 4-5: Flow cyfometric analysis ofNF-KB in K562 cells by histogram. (a) NF-KB
protein expression in untreated control K562 cells. The percentage of NF-ICB positive
cells is 42.23% and NF-ICB negative cells is 58.39%. (b) NF-KB protein expression in
sanguinarine induced apoptotic K562 cells. The percentage of NF-ICB positive cells is
17.38% and NF·KB negative cells is 83.17%. (c) NF-xB protein expression in K562 cells
that underwent sanguinarine induced BCD. The percentage of NF-KB positive cells is
60.14% and the percentage of NF-KB negalive cells is 41.28%. (d) NF-ICB protein
expression in untreated control 1Ml cells. The percentages ofr>.'F-KB positive cells and
NF-KB negative cells are 83.65% and 16.74%, respectively. (e) NF-KB protein
expression in 1MI cells exposed to the concentration (and duration) of sanguinarine that
induce apoptosis in K562 cells (1.5 Ilglml). The percentages ofNF-KB positive cells and
NF-KB negative cells are 81.13% and 19.33%, respectively. (f) NF-ICB protein expression
in 1M1 cells exposed to the concentration and duration of sanguinarine that induced BCD
in K562 cells (12.5 Ilglm1). The percentages ofNF-KB positive cells and NF·KB negative
cells are 80.85% and 19.63%, respectively
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Abstract
The multidrug·resistant (MDR), permeability-glycoprotein (Pgp) positive CEM-
VLB 1000 human leukemia cells and its wild type CEM-H, when treated with the
alkaloid sanguinarine, were found to undergo apoptosis or programmed cell death (PCD)
at concentrations of 1.5 J.Ig1ml and blister cell death (BCD) at concentrations of 12.5
J.Ig1ml. Pgp positive cel1s are known to be encoded by the multidrug-resistance gene
(MDRI), and characterized by a reduced ability to accumulate drugs. However, when
intracellular levels of sanguinarine were measured by flow cytometric analysis in CEM-
VLB 1000 cells treated with sanguinarine, we observed low levels during PCD, but high
levels during BCD. Furthermore, the cell death processes ofPCO and BCD of both cell
lines were found to be qualitatively similar when assessed by light microscopy, terminal
deoxynucleotidyl transferase (TdT) end.labeling, annexin V binding, trypan blue
exclusion and clonogenic assay. Western blotting analysis revealed an increase in the
BaxIBcl·2 ratio and activation of caspase 3 in PCD but not BCD in both cell lines
Therefore. we conclude that sanguinarine may overcome the phenomenon of MDR in
CEM.vLB 1000 cells by inducing PCD through increasing the BaxlBcl-2 ratio and
activating caspase 3, and BCD. which involved neither.
Introduction
Sanguinarine (or bloodfO()() belongs to the benzophenanthridine alkaloid group,
which are biosynthesized from phenylalanine in plants of the Papaveraceae family
(Dostal and Potaeek, 1990; lmanek, 1985). This alkaloid has been reponed to display a
wide spectrum of biological effects, such as antifungal, antimicrobial, analgesic and
moreover, anti-cancer propenies (Doslal and Potacek. 1990; lmanek, 1985; Vavreckovil
and Ulrichova, 1994; Ahmad el aJ., 2000). Its principal use today is in over-the-counter
products including toothpaste, mouthwash, cough and cold remedies, and homeopathic
preparations (Babich et ai" 1996), Sanguinarine has also been reported to be a protein
kinase C (PKC) and NF-KB (nuclear transcription factor KB) inhibitor (Gopalakrishna el
aJ., 1990; Chaturvedi el aJ., 1997), a DNA intercalator (binding to guanosine-cytosine
rich regions) (Babich el al., 1996; Sen and Maiti, 1994), a topoisomerase 1 and n
inhibitor (Hsiang et aI., 1989; Zhang et aI., 1990), an inhibitor of tubulin assembly
(Wolff and Knipling, 1993) and an inhibitor of Na-/K- ATPase (Seifen elo1., 1979;
Straub and Carver, 1975).
Resistance of maJignant tumors to chemotherapeutic agents remains a major cause
of failure in cancer therapy (Ling, 1997). A multigene family designated MDR (Endicot
and Ling, 1989, Kang el al., 2000) has been identified, the members of which encode a
family of membrane glycoproteins tenned P- g.Iycoproteins (Nooter and Herweijer, 1991;
BoTSt, 1991; Juranka ef 01., 1989; Endicot and Ling, 1989). P-glycoprolein appears to
function as an energy-dependent transport pump capable of effiuxing cytotoxic agents
and thereby decreasing their intracellular concentration (Hamada and Tsuruo, 1988). The
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MDR gene, overexpressed in multidrug·resistant cell lines, is associated with poor
prognosis for then.py (ling, 1997; Bosch and Croop, 1996).
Apoptosis or PCD is a highly regulated process thai results physiologically in the
selective death of cells. The cell death pathway may be conceived as a series of
intracellular decision points where death regulatory genes are activated in response to
physiologic or pathologic signals. The Bc1·2 family of genes is a major component orthis
pathway, serving as both positive and negative regulat0f5 of cell death. The intracellular
level and the ratio of Bcl-2 and Bcl-2-related proteins dictate if a cell should engage in
the apoptotic program (Reed, 1997a; Reed, 1997b). It has also been suggested thai the
relative amounts of Bc1-2 and Bax may be considered as a ''rheostat'' which determines
the susceptibility ofa cell to undergo apoptosis (Korsmeyer el aJ., 1993).
Apoptosis has been known to be execuled by a family of cysteine proteases called
caspases (Nuiiez el aJ., 1998). The activation of caspase-3 leads 10 proteolytic activation
of downstream effector caspases and the cleavage of a number of vilal proteins, resulting
in the orderly demise of cells (Nunez et aJ., 1998; Salvesen, 1999). In contrast 10
apoplosis, little is known about cell death by bliSler formation.
Our previous studies have demonstrated that K562 human erythroleukemia cells,
when exposed to the alkaloid sanguinarine at concentrations of 1.5 }!glmI and 12.5 }!gfml
for twO hours, displayed the morphologies of two different modalilies of cell death: at 1.5
}!gfml the classical morphology ofapoptosis or programmed cell death (PCD) and at 12.5
}!gfml, the morphology of single blister formalion or blister cell death (BCD)
(Weerasinghe el aJ., in press). Previous observations in our laboratory of apoptosis or
programmed cell death (PCD) and blisler cell death (BCD) induced by the semisynthetic
benzophenanthridine alkaloid derivative Ukrain™ in K562 cells was tCfTlled "bimodal
ceU death" (BMCD) (Liepins el al., 1996). Thus, this dual cell death modality induced by
sanguinarine, a potent anti-cancer agent (Ahmad et aI., 2000), was also tCfTllcd "bimodal
cell death" (BMCO).
The objective of the present study was to characterize the effects of sanguinarine
treatment in the multidrug-resistant CEM-VLB 1000 human leukemia cells and in their
wild type CEM-T4 cells. We found that sanguinarine induced PCD and BCD in Pgp-
posith·e CEM-VLB 1000 cells and in their wild type Pgp-ncgativc CEM-T4 cells, al the
same conccntralions and unda- the same experimental conditions. This repon is also an
ancmpt to bctta- understand the possible mechanisms by which sanguinarine overcomes
the drug effiux actions ofPgp in MDR cells.
Materials and Methods
Materials
The CEM-VLB 1000 and CEM-T. cell lines were kindly provided by Dr. Victor
Ling (University of British Columbia, Canada). These cells were cultured in RPMI 1640
medium supplemented with L. glutamate and 10% fetal calf serum. They were
maintained in a 3rC/5% CO2 fully humidified incubator and passaged 4·5 times weekly
Annexin-V-fluos staining kit for the detection and quantification ofapoptosis and
differentiation from necrosis at the single cell level was purchased from Boehringer
Mannheim Corp (Indianapolis, IN) The kit was stored and handled according to
manufacturer's instructions
Th, dms sanguinarine ([1,3]benzodioxolo[5,6-c]- I,3-dioxolo[4,5-
l]phenanthridinium, 13.methyl., chloride[9Cl]) was purchased from Sigma Chemicals
(St. Louis, MO) and maintained as a dry powder at room temperature, It was dissolved in
deionized water at I mg/ml and used as a stock solution. Sanguinarine was subsequently
diluted with RPMI 1640 in order to make a working solution of25 Ilg/ml
Drug treatment
The following experimental format was used in order to prepare the cells for
subsequent experiments. Logarithmically growing CEM-VLB 1000 and CEM·14 cells
were placed in 60 mm dishes at approximately 3xlO6 cells/ml, Thereafter, serially diluted
sanguinarine concentrations of 0.19, 0.39, 0,78,1.56,3.12,6.25,12.5 and 25 Ilg/ml were
added to the petri dishes and incubated for 2 hrs in a 37"C/5% C02 incubator. Cells that
underwent PCD and BCD (at concentrations of 1.5 Ilg/ml and 12.5 Ilg/ml respectively)
were used for morphological analysis, caspase-3 assay and protein isolation from cells
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Lightmicroscop)'
Cells treated with sanguinarine were studied and quantitaled by light microscopy.
l1Je key morphologica.l criterion for the detection of apoptosis was the formalion of
apoptotic bodies and the key criterion for blister cell death was the formation of cell
surface blisters.
Tryp.. blu~ assay
Charged cationic dye tryp8n blue is excluded from putative live cells with intact
plasma membranes. The changes in membrane permeability in CEM-VLB 1000 and
CEM·T4 cells which were exposed to sanguinarine treatment and in untreated controls,
were evaluated in triplicate wells at 2xlO4 cells per well after 2 hours of incubation at
3rC using flat bottom 96 well plates. After 10 minutes of incubation wilh the dye trypan
blue (0.20/0), the number of uypan blue excluding cells was cOUnted using a
hemocytometer. The exclusion of 0.2% trypan blue was used as an indicalOr of the
number of live cells.
aonogenic assay
This method for assessing cloning efficiency of cells was done as previously
described by Grant t!t 01. (1991), with minor modifications. Briefly, cells Ireated with
sanguinarine and untreated conlrols were plated, washed Iwice and resuspended in RPMI
1640. After determining cell densities by coulter counter, 400 ceJls were seeded in 35-
mm tissue culture plates containing 1 ml of RPMI, 20% fetal calf serum and 0.3% baeto
agar (Difco, Detroit, Ml). The plates were placed in a 3i'C, 5% CO2, fully humidified
incubator for 1O·1I days. Thereafter, colonies were stained with 2% crystal violet in
methanol and counted in an invened microscope.
Terminal deoxynuc1eotidyl tnnsferue (Tdn end-labeling a.nay
Specific 3'-hydroxyl ends of DNA fragments generated by endonuclease-
mediated apoplosis are preferentially repaired by terminal deoxynucleotidyl transferase
(Tdn (Gavrieli et ai., 1992). The TdT mediated nick end labeling assay has been
developed to label these strand-breaks with streptovidin-horseradish peroxidase
conjugated nucleotides followed by the addition of a substrate (TACS Blue LabclTlll or
TBL).
After sanguinarine treatment, cells were removed from individual wells, washed
in phosphate buffered saline (PBS) and fixed in 10% neutral buffered formaldehyde for
10 minutes. Thereafter, cells were resuspended in 80% ethanol at IxlO6 cells per ml.
50,000 cells were placed onto an electrostatically treated glass slide and air-dried at room
temperature. CeJls were then permeabilized with proteinase K (Gavrieli et aI., 1992) and
incubated for 60 minutes al 37"C in the presence and absence of exogenous TdT and
streptavidin-hol'SCnldish peroxidase conjugated dNTP (deoxynucleotide triphosphate),
followed by the substrate TBL according to the manufacturer's instructions (Sigma
TACSn.l in situ Apoptosis Detection Kit, St. Louis, MO). Cells were then examined and
pholographed under phase microscopy and counted 10 determine the percentage of cells
with DNA nicking to total cells.
Fluorescein-conjugatM annes.in·Y-binding assay
After Ireatment with sanguinarine concentrations thai induce PCD and BCD, CEM-VLB
1000 and CEM-T4 cells (lxJ06 cells) were washed with PBS and incubated with
annexin-V fluorescein isothiocyanate (FJTC) conjugate and propidium iodide (PI)
utilizing an annexin-V-Fluos staining kit (Boehringer Mannheim Corp, Indianapolis, 11\').
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After labeling, cells were resuspended in binding buffer and analyzed using flow
cytometry. FlTC·fluorescence was measured at 530-545 nm and fluorescence orONA-PI
complexes at 575-606 nm. Cell debris was excluded from analysis by appropriate
forward light scaner threshold setting (Leist et 01., 1997).
Expression ofPgp in cell surface
CEM-VLB 1000 and CEM-T4 Cells were incubated for 30 mins with MDRt
antibody (0.5 llg for 106 cells) or non-specific murine IgG2a, After washing with PBS
twice, cells were incubated with FITC conjugated F(ab')2 fragment of sheep anti-mouse
immunoglobulin (50 III of 1:200 dilution). After 30 mins, cells were washed with PBS
twice and held at 411C in the dark until analysis by flowcytometry (Kunikane el 01., 1997),
Detection of sanguinarine auto-fluorescence
Subsequent to drug treatment, cells were washed 3 times and subjected to flow
cytometric analysis. Measuring of intracellular sanguinarine fluorescence was done using
a Becton Dickinson flow cytometer
5DS-PAGE and Weslern blotting analysis
The following experimental format was used in order to prepare the cells for
subsequent western blotting analysis. Logarithmically growing CEM·VLB 1000 and
CEM-T4 cells were placed in 15 mm petri dishes at around 3xl06 cellfml. Thereafter,
serially diluted sanguinarine concentrations of 0.19, 0.39, 0.78, 1.56,3.12,6.125, 12,5
J.lglml were added to the petri dishes and incubated for 2 hrs in a 3rC15% C02 incubator.
Expression of Bc1.2, Bax, Bsk, Bad, BiklNbk, Bcl·Xs, Bid, BcI-XL, p53, and
CPP-32 proteins were detennined by western blotting analysis using previously described
methods with minor modifications (pixto", 1990; Towbin et 01., 1979). Briefly, after
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treatment with sanguinarine, whole cell pellets (lx107 celUdish) were washed twice in
PBS, resuspended in 50 III PBS and lysed by adding lysis buffer solution. The
homogenates were quantified using DC protein assay. Equal amounts of proteins (20
llglwell) were boiled for 5 minutes, separated by sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (5% stacking gel and 12% resolving gel) and electrobloned to
nitrocellulose. After blocking with PBS tween 20 (0.05%) and with 5% non-fat dried
milk for I hr at 22°C, the blots were incubated in fresh blocking solution with an
appropriate dilution of primary antibody (Santa Cruz Biotechnology, Inc., Santa Cruz,
CAl. For the study ofCPP-32, primary antibody was used at 1:250. Blots were washed 3
times for 5 min in TBS-T and then incubated with 1:2500 dilution of horseradish
peroxidase conjugated secondary antibody (Santa Cruz) for I hr at 22°C. Blots were
again washed 3 times for 5 minutes in TBS·T and then developed by chemiluminescence
(Amersham, Arlington Heights, IL).
Statistical analysis
The results are presented as means ± SE. Statistical analyses were performed
using the student's t test. Differences were considered significant when p< 0.05.
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Results
Morphological studies by light microscopy showed that CEM-YLB 1000 and
CEM-T4 cells, when treated with sanguinarine at concentrations of 1.5 Ilglml displayed
the morphology of apoptosis in over 90"10 of cells, and at concentrations of 12.5 jlglml,
blister formation in over 85% (Fig.S-I). Results of trypan blue studies for cell viability
showed over 90"10 of PCD and BCD of both cell lines excluding trypan blue (fig.s-2).
The c1onogenic assay to measure cell viability showed no colonies in PCD and BCD of
both cell lines as compared with control untreated cells (fig.S-3).
DNA fragmentation in PCD and BCD of both cell lines was assessed by the
tenninal deoxynudeotidyl transferase (TdT) end-labeling method. Results showed DNA
nicking in over 88% in PCD of both cell lines but not in BCD (fig.S-4)
The annexin-V-assay was utilized for the detection of cell surface membrane
phosphatidyl serine (PS) flip, which is known to be associated with apoptosis or PCD
(Leist et aI., 1997). Sanguinarine-induced apoptotic CEM-YLB 1000 and CEM-T4 cells
showed over 60% of annexin-V positive cells, i.e. binding of annexin-V to phosphatidyl
serine on the surface of the cell membrane as compared to about IS% in untreated control
cells. However, cells of both cell lines that underv.rent BCD did not show the PS flip
(fig.5-5)
Detection of Pgp expression in cell surface was done using immunofluorescence-
flow cytometry with FITC fluorescence. Over 99% of CEM-VLB 1000 cells displayed
FITC fluorescence when treated with the MDRI antibody. In contrast, MDRl antibody-
treated CEM-T4 cells showed no FITe fluorescence. CEM-T4 and CEM-YLB 1000 cells
treated with the isotype IgG (negative controls) did not show fluorescence (fig.s-6)
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Flow cylometric detection of sanguinarine uptake by measuring its auto-
fluorescence showed relatively low levels in PCD of both cell lines but considerably
higher levels in BCD (fig.s-7). Intracellular sanguinarine levels in PCD and BCD of
CEM-T4 cells were comparable 10 those of PCD and BCD of CEM-VLB 1000 cells,
respectively
Western blotting analysis was done to study the protein expression during
sanguinarine-induced PCD and BCD in both cell lines. These studies were limited to
analyzing the expression of the Bc1-2 family gene products. The expression of the 21 kDa
pro-apoptotic Bax protein was found to be moderately increased in sanguinarine-induced
PCD in both cell lines as compared to untreated control cells. In contrast, sanguinarine-
induced BCD did not show any significant change in Bax protein expression (fig.5-8A).
No change was observed in the expression of the 26 kDa anti-apoptotic Bcl-2 protein in
neither PCD nor in BCD in either of the cell Jines (fig.5-SB). The 32 kDa endogenous
caspase 3 was inherent in both cell lines. However, it's 20 kDa breakdown products,
denoting activation, was only observed in FCD of both celliines but not in BCD (S-Se)
The expression of pro-apoptotic Bak, Bad, BiklNbk, BcI-Xs, Bid, pS3 and anti-apoptotic
BcI-XL proteins was not significantly affected by sanguinarine in either cell line at low
level or high level (individual data nOl shown)
Discussion
Our resuJts show thai, Pgp.positive CEM-VLB 1000 and Pgp.negative CEM-T4
cell lines underwent similar patterns of PCD and BCD, both qualitatively and
quantitatively during sanguinarine treatment. When exposed to sanguinarine at
concentrations of 1.5 IlWml and 12.5 IlWml for 2 houn, both cell lines showed the
morphology ofPCD in over 9<)010 of cells and BCD in over 85% ofcells, respectively. In
contrast to BCD, the PCD induced by sanguinarine showed DNA nicking and the
phosphatidyl serine (PS) flip, commonly associated with PCD or apoptosis. Both PCD
and BCD were found to have membrane viability by the exclusion of trypan blue but
failed to have long term survival in the clonogenic assay.
Western blotting analysis revealed a moderate up-regulation of the Bax protein in
sanguinarine-induced PCD in both cell lines, while Bcl·2 levels remained unchanged.
Our previous studies have shown that high le'ids of endogenous BcI·2 protect 1M1 pre-B
lymphoblastic cells from undergoing bimodal cell death, when treated with sanguinarine
(Wecrasinghe et aI., in press). These findings illustrate the importance of the BaxJBcl·2
ratio in the induction of PCD (Korsemeyer, 1999). Funhermore, this ratio has been
shown to correlate with the chemotherapeutic effect (Nakata et 01., 1998; Yin et 01.,
1994). On the Other hand, prOtein expression analysis of BCD revealed no significant
changes in Bc1-2 family protein expression as compared to untrealed control cells and did
not appear to show the increased expression of Bax seen in PCD. Other members of the
Bcl-2 family, including Bak, Bad, Bik, Bel·Xs, Bel-XL and Bid. as well as the tumor
suppressor p53 appear not to play any significant role in either pen or BCD.
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Immunofluorescence and flow cytometry studies showed the presence of the
transmembrane glycoprotein- Pgp in the MDR CEM-VLB 1000 cells but not in CEM·T4
cells. We have also shown the elevated presence of sanguinarine-fluorescence in cells by
flow cytometry in BCD of both cell lines relative to PCO. Thus sanguinarine may have
overcome the Pgp-mediated drug emux pump by inducing a less understood form of cell
death- BCD, and not by PCO which was also induced by the drug. Sanguinarine is known
to exen it's anti-cancer propenies, among other mechanisms, by forming a molecular
complex with DNA by binding to regions rich in cytosine.guanosine (Sen and Maiti,
1994; Babich el af., 1996). The influx of drug into the cell in BCD may aid or even
potentiate sanguinarine intercalation, and contribute towards its potency as an anti-tumor
agent
Necrosis represents not a form of cell death but changes secondary to cell death
by any mechanism (Majno and loris, 1995). It is known that early necrotic cells lose
plasma membrane integrity, thus permitting the entry of trypan blue and propidium
iodide into the cell (O'Brien el af., 1997). The exclusion of trypan blue and propidium
iodide by BCD in cells indicate that BCD is not representative of early necrosis. Blister
formation is at best, only sporadically reported in literature (Liepins el af., 1996; Phelps
el af., 1989). The phenomenon of BCD may resemble the "blebbing" described by Majno
and loris (Majno and loris, 1995). Majno and loris describe blebbing as blister-like,
fluid-filled structures, typically devoid of organelles that arise from the cell membrane
and are apt to swell and burst. Trump el af. (1997) and Trump and Berezesky (1992)
associates blebbing with increases in concentration of cytosolic Ca2+ [Ca--+]i and
rearrangement of cytoskeletal proteins including filamentous actin, The rupture of these
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large cell surface blebs is thought to represent the abrupt transition from reversible to
irreversible cen injury (Lemasters et ai., 1987).
Considerable attention has been devoted to studying the activation of the protease
cascade in drug-induced and other forms ofapoptosis, as well as on the ability ofBcl·2
and related proteins to inhibit this process (Wang et at., 1997). Our results showed that
sanguinarine-induced PCD activated caspase 3, while BCD failed to do so. Our previous
studies have shown that sanguinarine treatment of Bcl·2 low-expressing K562 cells
resulted in the activation/cleavage of caspase·3 into 20 kd CPP-32 breakdown products,
whereas the BcI-2 over-expressing 1MI cells showed no breakdown products ofCPP-32
(results not shown). Therefore, in the presence of elevated Bcl-2, sanguinarine may have
been unable to trigger caspase 3 activation, which is in agreement with several recent
reports (Kojima et ai., 1996; Irabo et al., 1996). These results also appear to be consistent
with recent literature, which suggests that in the case of some, but perhaps not all
cytotoxic stimuli, Bcl·2 functions upstream of a critical cysteine protease involved in the
degradation phase ofapoptosis (Wang e/ at., 1997). As opposed to Bcl-2, increased levels
of Bax promotes caspase 3 activity in sanguinarine-induced apoptosis, which is
corroborated in the present study. In contrast, the absence of caspase 3 activation during
BCD may indicate that this may not be a necessary element in the execution of BCD
Apoptosis is not the sole cell death mechanism (Houghton, 1999). Our findings
show that, at least in the case of sanguinarine, tumor cell death may also be induced by
BCD-a hitherto less understood fonn of cell death. Furthermore, sanguinarine may
overcome the phenomenon ofMOR in the CEM-VLB 1000 cell line by inducing BCD as
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well as PCD. Sanguinarine may therefore be explored as a potential ami-cancer drug in
reversing drug-resistance in the chemotherapy of common malignancies.
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~ Light micrographs (original magnification- x282) of CEM-VLB 1000 and
CEM-T4 cells treated with sanguinarine. Control, apoptosis and blister cell death (BCD)
ofCEM-VLB 1000 cens are shown in figs. (a), (b) and (c), while control, apoptosis and
BCD ofCEM-T4 cells are represemed by figs. (d), (e) and (t), respectively. Both cell
lines treated with sanguinarine at 1.5 Ilglml and 12.5 Jlglml respectively for 2 hrs showed
the morphology ofapoptosis (arrows) and BCD (arrows).
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Figure 5·2: Trypan blue exclusion assay in sanguinarine treated CEM-VLB 1000 and
CEM·T4 cells. As shown, quantitative trypan blue exclusion showed over 9QO/o of cells of
both cell lines that undetwent PCD or BCD excluding the dye. Results represent the
mean ± SE from 3 independent experiments.
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~: Clonogenic assay for CEM-VLB 1000 and CEM·T4 cells treated with
sanguinarine. The graph shows survival cell fraction, expressed as the ratio of the colony
forming cells of drug treated and untreated cells. PCD and BCD of both cell lines induced
by sanguinarine showed no colony formation. Experiments were repeated three times.
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~: Terminal deoxynucleotidyl transferase (TdT) end labeling assay in CEM-
VLB 1000 and CEM-T4 cells treated with sanguinarine was used to detect DNA damage.
Sanguinarine-induced apoptolic cel1s of both cell lines showed DNA nicking (b and e),
whereas, BCD of both cell lines (c and f) as well as untreated controls (a and d) failed to
show DNA nicking
ll6
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~ Annexin-V-binding assay in CEM-VLB 1000 and CEM-T4 cells treated with
sanguinarine. The cell surface membrane phosphatidyl serine flip in sanguinarine induced
apoptosis (1.5 j.Ig1ml) and blister cell death (12.5 j.Ig/ml) in both cell lines were measured
using annexin-V and FITC staining with subsequent quantitation of annexin-V positive
cells by FACS analysis. As shown, apoptosis of both cell lines had annexin-V-binding
while all other cell samples (control and BCD) failed to show the PS flip. Each data point
represents the mean ± SE from three independent experiments.·, p<O.05 is the statistical
significance of the difference in annexin-V-binding between sanguinarine-treated CEM-
VLB IOOO/CEM-T4 cells at apoptosis-inducing concentrations and controls of these
respective cell lines
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Figure 5-6" Cell surface Pgp expression in CEM-VLB tOOO and CEM-14 cells. Peaks "b"
and "d" show Pgp-positive CEM-VLB 1000 cells and Pgp-negative CEM-T4 cells,
respectively. As shown in the histogram over 95% of CEM-VLB 1000 cells were Pgp
positive. Both "a" and "c" peaks show Pgp-negative controls. The X-axis shows the
intensity of FITC fluorescence and Y-axis shows cell counts
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~ Flow cytometric dot plots for the detection of sanguinarine auto-fluorescence
in CEM-T4 and CEM-VLB 1000 cells. Propidium iodide (PI) fluorescence levels in PCD
ofCEM-VLB 1000 and CEM-T4 cells are represented by (b) and (e), and that of BCD
are represented by (c) and (t), respectively. Control untreated CEM-VLB 1000 and CEM-
T4 cells are shown in (a) and (d), respectively. The X-axis show FITC fluorescence
intensity and Y-axis show intensity of PI fluorescence. Sanguinarine fluorescence levels
in PCD and BCD of CEM-VLB 1000 cells were comparable to that in PCD and BCD
respectively, ofCEM-T4 cells.
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~: Western blot afRax: protein expression in peD and BCD ofCEM·VL8
1000 and CEM-T4 cells treated with sanguinarine. Lanes 1, 3 and 5 show control, peD
and BCD ofCEM-T4 cells, while lanes 2, 4 and 6 show control, peD and BCD ofCEM·
VLB 1000 cells. As shown, the 21 kDa Sax band is moderately elevated in peD of both
cell lines. The elevation of the Bax band in BCD was not significant.
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~: Western blot of Bc1-2 protein expression in PCD and BCD ofCEM-VLB
1000 and CEM-T4 cells treated with sanguinarine. Lanes J, 3 and 5 show control, PCD
and BCD ofCEM-T4 cells, while lanes 2, 4 and 6 show control, PCD and BCD ofCEM-
VLB 1000 cells. Lane 7 is the positive control. Results show no change in the 26 kDa
Bcl-2 levels in sanguinarine treated cells.
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~: Western bIoI of CPP-32 protein expression and of its 20 Kd breakdown
product in peD and BCD ofCEM-VLB 1000 and CEM·T4 cells, Lanes 1.3 and 5 show
control, PCD and BCD of CEM-T4 cells, while lanes 2, 4 and 6 show control, peD and
BCD of CEM-VLB 1000 cells. Lane 7 is the positive controL Results show the 20 kDa
breakdown product only in peD ofboth cell lines.
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Summary and Future Directions
Summary and Future Directions
Sanguinarine-induced bimodal cell death in our view is a unique phenomenon,
about which very little is reponed in literature. Its components PCD (or apoplosis) and
BCD (as we have chosen to name it) are two different forms of cell death. The
information reponed on PCD on an almost daily basis is truly extraordinary. This stands
in sharp contrast to the paucity of literature available on BCD. During the course of my
present study period, we have found that bimodal cell death (BMCD), i.e. apoptosis and
BCD induced by sanguinarine a convincing model for the study of both these cell death
phenomena. As pointed out in the preceding chapters, the percentage of apoptosis and
BCD induced by sanguinarine in K562 erythroleukemia cells, the MDR CEM-VLB cells
or in their wild type counterparts CEM-T4 cells are> 90% and >85% respectively. This
feature alone would make sanguinarine-induced bimodal cell death very attractive for the
study of apoptosis and BCD
In essence, the present study leading to this thesis revolved around several key
issues, which we believe, are inter-related. These broadly comprise of, characterizing
sanguinarine-induced PCD and BCD at the cellular and molecular levels, investigating
the effects of Bcl-2, BaxIBcl-2 ratio and the multidrug-resistant protein P-gp in the
susceptibility of cells to sanguinarine, and also detennining the role of BCD as a novel
form of cell death. These issues were addressed within the context of four chapters
(papers).
We found that the Bcl·2 low·expressing K562 cells (Kobayashi et aJ., 1998),
when treated with sanguinarine concentrations of 1,5 ).lglml, underwent the morphology
of apoptosis, and when treated with concentrations of 12.5 ).lglml, underwent the
morphology of BCD. Characterization of the cellular parameters of sanguinarine-induced
PCD and BCD in the Bc1·2 low-expressing K562 cells was done by measuring multiple
parameters, using light and electron microscopy, 51Cr release, TdT end labelling,
annexin-V-binding and trypan blue and propidium iodide exclusion assays (see table I).
ll2.J.U Characteristics of apoptosis or programmed cell death (PCD) vs blister cell
death (BCD)
Criteria Apoptosis or progranuned
cell death (PCD) in K562
cells
Blister Cell Death (BCD) in
KS62 cells
morphology as
studied by light and
electron microscopy
cell injury
measured by
release assay
cell viability and
plasma membrane
integrity as measured
by trypan blue and
propidium iodide dye
exclusion assays
displayed fonnation of displayed fonnation of blisters
apoptotic bodies containing (often one, but rarely two)
organelles, chromatin devoid of organelles, patchy
condensation, and nuclear chromatin condensation, and
fra.lZ:mentation increase in vacuolization
showed a relatively lower showed a relatively higher
degree of injury; degree of injury;
approximately 20% of SICr approximately 40% of 'lCr
released released
demonstrated viability by demonstrated viability by
excluding both dyes excluding both dyes
membrane PS flip as showed PS flipping
detected by the
annexin-V-assa
DNA nicking as showed DNA nicking
measured by the TdT
end labelling method
Bax protein increase in Bax expression
expression as
measured by western
bloning and flow
cytometry
showed no PS flipping
showed no DNA nicking
no change in Bax expression
Bcl-2 protein no significant change in Bcl·2 no significant change in Bcl-2
expression as expression expression
measured by western
blotting and flow
cytometry
NF·/(B protein decrease in NF-/(B expression increase in NF·/(B expression
expression as
measured by flow
cytometry
ll3
Caspase.3 activation involved Caspase-3 activation
involved
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The differences between PCD and BCD, in light of these cellular assays were
discussed. In general, all the above experiments showed significant differences between
both forms of cell death, with the exception of trypan blue and propidium iodide dye
exclusion assays. This leads us to the topic of BCD versus Necrosis.
Often BCD is associated with the necrotic process; thus leading to confusion. As
we have noted elsewhere, the nomenclature of cell death is constantly being debated by
the society of toxicologic pathologists and other regulatory bodies, and thus is an
evolving process (Levin et aJ., 1999). We subscribe to the theory that necrosis does not
represent a form of cell death, but merely constitutes changes secondary to cell death.
BCD by virtue of excluding propidium iodide and trypan blue may not represent necrosis.
We have also observed morphologic similarities between BCD and the ''blebbing
phenomenon" found in the literature (Majno and Joris, 1995; Trump et al., 1997). This
was discussed at length in the preceding chapters
BcI-2 high-expressing JM I cells, when treated with concentrations of sanguinarine
that induce PCD and BCD in K562 celis, failed to undergo the corresponding
morphologies which were observed in K562 cells treated with sanguinarine. This failure
by 1Ml cells to undergo the relevant morphologies was accompanied by an increase in
the levels of BcI-2 at both concentrations. Sanguinarine treatment of K562 cells, on the
contrary, showed an increase in Bax at the lower concentration with no significant change
in BcI·2 levels (see table I). These results clearly show the importance of the BaxlBcI-2
ratio and its association with susceptibility of cells to sanguinarine-induced apoptosis; the
increase in this ratio is also widely reponed in literature to be associated with the
apoptotic process (Korsemeyer, 1993). The detection of this ratio may prove to be a
valuable prognostic marker in oncology
Interestingly, as aforementioned, treatment of the BeI-2 high-expressing 1M1 cells
with sanguinarine at low and high concentrations resulted in an increase in the levels of
BeI-2. Our experiments show that the increase in BeI-2 is a better indication of the
susceptibility of cells to Wlguinarine-induced apoptosis and BCD, than the endogenous
BeI-2 levels in cells. Further evidence of this was seen in experiments with CEM-VLB
IOOO/CEM·T4 cells. Both cell lines, despite showing moderate levels of endogenous BeI-
2, underwent bimodal cell death (BMCD) with relative ease when treated with the high
and low concentration of sanguinarine; there was no increase in levels of Bcl-2 in either
cell line, compared to untreated controls. In 1Ml cells, the concomitant increase ofBeI-2
when treated with sanguinarine may be asrociated with the resistance to apoptosis and
BCD that these cells demonstrate. The BeI·2 gene product is widely associated with
chemoresistance by virtue of its anti-apoptotic nature (Reed, 1998; Korsemeyer, 1999)
Recent evidence indicates that Bcl-2 may also inhibit the "blebbing" phenomenon (Ferri
et al., 2000). We propose that the chemoresistance caused by the increase in BeI-2 might
be associated with its dual role of anti-PeD and anti·BCD, and thus may have potential
clinical implications.
The cell death processes of PCD and BCD were also characterized at the molecular
level. The expression of BeI-2 family proteins, p53 and caspase-3 activation was assessed
in both forms of cell death using western blotting technology. Results indicate that
sanguinarine induced apoptosis involves caspase-3 and Bax by post-translational
modification, whereas sanguinarine induced BCD involves neither caspase 3 nor Bax in
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K562 cells. Evidence of de novo protein synthesis-independent apoptosis is well
demonstrated in the literature (Reed, 2000). These results of western blotting studies were
confirmed using immunofluorescence-flow cytometry; that of increase in pro·apoptotic
Bax in sanguinarine-induced apoptotic K562 cells and the increase of Bcl·2 in JM I cells,
when treated with the drug.
We also discussed the involvement of the nuclear transcription factor NF·......B in
sanguinarine-induced PCD and BCD (chapter 4). Immunofluorescence-flow cytometry
studies showed that in response to sanguinarine treatment, K562 cells decreased NF-/(B
during PCD; this was in sharp contrast to the increase in NF-/(B during BCD. The anti-
apoptotic nature of NF-/(B is well known (Kajino et al., 2000), and corroborates our
findings of reduction in NF-/(B in apoptosis. In contrast, the increase in NF·/(B in BCD
may be associated with a pro·BCD function
Sanguinarine was also found to overcome the P-glycoprotein mediated drug efflux
pump in multidrug-resistant (MDR) CEM-VLB 1000 cells. This we attributed, as
discussed earlier, to the influx of sanguinarine into the cell during BCD, thereby
facilitating its intercalation with DNA. It was shown that PCD and BCD induced by
sanguinarine in CEM-VLB 1000 cells and in its wild type counterpans CEM-T4 (P-gp
negative) were qualitatively similar. This was demonstrated when sanguinarine induced
PCD and BCD in both cell lines was assessed by standard methods, at both cellular and
molecular levels. Western blotting analysis revealed an increase in the BaxlBcl-2 ratio
and activation of caspase 3 in PCD but not BCD in both cell lines. Therefore, we
concluded that sanguinarine may overcome the phenomenon of MDR in CEM·VLB 1000
cells by inducing PCD through increasing the BaxIBcl·2 ratio and activating caspase 3,
and BCD, which involved neither. Sanguinarine may therefore be explored as a potential
anti-cancer drug in reversing drug-resistance in the chemotherapy of common
malignancies
We have dwelled on describing the paucity of information on non-apoptotic foons
of cell death, despite having found that apoptosis may not be the sole cell death
mechanism (Houghton, 1999; Trump et aI., 1997). We believe that the identification and
characterization of the different modalities of cell death induced by potential anti-cancer
drugs may be important in the war against cancer. Understanding different cell death
mechanisms of individual anti-cancer agents may lead to their effective administration,
alone or in combination with other established therapies. Thus, the need to identify and
characterize novel cell death modalities of potential anti-cancer agents remains.
Based on our results, we may be able to hypothesize on a probable genetic regulation
of BCD, as was also suggested by Trump et al. (1997) and Shirai (1999). Many would
find this statement rather presumptuous. It is for this precise reason that we propose this
line of thought as an avenue for essential future investigations. Further analysis of BCD
at the cellular and molecular levels (especially at the early stages and at different time
periods) might shed more light on this novel cell death modality. It is known that many
factors such as, cell death inducing agent, its dose and the type of cen line contribute to
the molecular changes that are triggered during cell death (Yanagihara and Tsumuraya,
1992). As such, in general, it is desirable that protein expression of BCD be studied in
different cell lines, with several death inducing agents at different doses and time periods
of exposure. As previously stated, our cel1lines (with the exception of 1Ml) showed
BCD when exposed to sanguinarine concentrations of 12.5 ~glml, for 2 hrs. We are
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particularly interested in studying the protein expression pallems at earlier time periods,
i.e. 15,30,60 and 90 mins, when K562 cells are exposed to sanguinarine at the BCD
inducing concentration of 12.5 ).lgfml It wiU also be interesting to know the changes at
the gene transcript level at these time periods, when analyzed using eDNA array
technology. These studies may help to reveal any possible genetic regulation of BCD.
Similarly, sanguinarine-induced apoptosis may also be studied along the lines
described above, i.e at IS, 30, 60 and 90 mins of exposure ofKS62 cells, at the apoptosis-
inducing drug concentration of 1.5 Ilgfml. This may help reveal the protein expression
patterns in apoptosis, palticularly of the Bcl-2 family and the BaxIBcl-2 ratio, at the early
stages, This ratio, as also repolted by other investigators, could be a valuable prognostic
tool for common malignancies (Korsemeyer el 01., 1993; Korsemeyer, 1999). Thus, in a
clinical sening, early detection of this ratio is of value. We are also keen on fulther
investigating the lesser-known role oftbe increase in the anti-apoptOlic BcI-2, as a factor
contributing towards chemoresistance, As aforementioned, K562 cells, CEM-VLB 1000
and its wild type underwent apoptosis and BCD when induced by sanguinarine while
showing no increase in BcI·2 levels; sanguinarine-trea!ed 1M1 cells, on the contrary,
showed an increase in BcI·2 levels while resisting apoptosis and BCD. Therefore, it
would be interesting whether this phenomenon could be observed during sanguinarine
treatment in other cell lines with varying levels of endogenous BcI-2.
As mentioned before, we found no de /lOVO protein synthesis in apoptosis as was also
reported in the literature (Reed, 2000). Reed (2000) has suggested that, in apoptosis, post-
translational modification of BcI-2 proteins might take place by their
phosphorylation/dephosphorylation and that conformational changes of Bax is associated
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with its translocation to and insertion into mitochondria membranes. Based on this, it
would be interesting to study these possible changes of Bcl-2 and Sax in relation to our
experiments, using eletrophoretic mobility shift assay and immuno-electron microscopy,
respectively
In order to further strengthen our results, we would also like to transfect our cell lines
with Bax and Bc\-2 and repeat the experiments with sanguinarine. K562 cells transfected
with Bc\-2 as well as 1MI cells transfected with Sax could be used for this purpose.
These experiments may further confirm the value of the BaxIBcI-2 ratio in sanguinarine-
induced apoptosis and the consistency of the association of chemoresistance with the
increase in BcI-2 levels in apoptosis and BCD, as observed in our studies. As described
by Kobayashi et al. (Kobayashi et al., 1998), these transfections may also give us the
opportunity of studying spontaneous apoptosis due to Sax transfeetion and compare that
with the apoptosis induced by sanguinarine
Finally, this thesis may not be complete without reference to the potential anti-cancer
effects of sanguinarine, about which many reports are found in the literature. As
previously described in detail, our results showed that sanguinarine induces tumor cell
death by pcn and Bcn in K562 cells, found to be rather resistant to apoptosis and also
to overcome the P-gp mediated MDR phenomenon. It would be interesting to document
the effects of sanguinarine in ",·ivo. Dose-response studies with sanguinarine may be done
in tumor-bearing mice; multiple parameters can be measured including tumour size and
immunological indices such as immune effector cell cytolytic activity.
The past few years have seen a rapid advance in the understanding of cell death. As
new concepts such as apoptosis appeared and the discovery of new and additionally
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forms of cell death are pursued, some conceptual and semantic strains developed; a recent
reviewer saw fit to oonclude that "there is no field of basic cell biology and cell
pathology that is more confusing and more unintelligible than is the area between
apoptosis versus necrosis" (Majno and loris, 1995).
In closing, I would like to quote from a review by Majno and Ioris·"We would like to
point out two facts. First. oncosis and apoptosis are merely two forms of cell death,
among many others that remain to be described. Consider, for example, that form of cell
death that makes histopathology possible, namely death by fixation. Histological fixatives
are designed to produce the perfect crime, death without visible traces. What shall we call
it? Second, in these days of molecular pathology. it is well to remember that the
marvelous story of apoptosis was initiated by a very simple. morphological observation,
accessible to the microscopes of our great-grandfathers,"
Would BCD attract the same attention as apoptosis?
Webelieve,yes
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